The Tasmanian devil and its transmissible cancer : physiology of the devil-DFTD interaction by Ruiz Aravena, MI
The Tasmanian Devil And Its 
Transmissible Cancer: Physiology 
Of The Devil-DFTD Interaction
Manuel Ignacio Andres Ruiz Aravena
Doctor of Veterinary Medicine
Submitted in partial fulfilment of the requirements for the degree of
Doctor of Philosophy
Life Sciences
School of Natural Sciences
July 2019
© Copyright by Manuel Ruiz Aravena 2019 
…to everybody who wanders in this world, 
wondering about how it works. 
I. STATEMENTS AND DECLARATIONS
Declaration of authority 
This thesis contains no material which has been accepted for a degree or diploma by the 
University or any other institution, except by way of background information and duly 
acknowledged in the thesis, and to the best of my knowledge and belief no material 
previously published or written by another person except where due acknowledgement is 
made in the text of the thesis, nor does the thesis contain any material that infringes 
copyright.
Signed: Manuel Ruiz Aravena
Date: December 2018 
Authority of access 
This thesis may be made available for loan and limited copying and communication in 
accordance with the Copyright Act 1968. 
S. d M 1 R . A 1gne · anue mz ravena 
Date: December 2018 

Scott Carver: Contributed to ideas and study design, assisted with data analysis and edited the 
manuscripts. 
Rodrigo Hamede: Contributed to ideas and study design, assisted with data analysis and 
edited the manuscripts. 
Camila Espejo, Sergio Estay and, Andrew Storfer: Contributed to ideas, and interpretation of 
results. 
We, the undersigned agree with the above stated "proportion of work undertaken" for each of 
the above published ( or submitted) peer-reviewed manuscripts contributing to this thesis. 
Menna Jones 





II.   PREFACE 
I moved from Patagonia to Tasmania to do my PhD in the study of devils and their 
transmissible cancer that affects them from a “conservation medicine” approach. Soon 
though, after extensive and sometimes exhausting conversations and discussions with 
supervisors and colleagues, my project started mutating (I have since learned that is what a 
PhD is about). The journey took me into concepts and dimensions of the host-pathogen 
interactions that I had not seen before as a veterinary student or in veterinary practice: Host 
and pathogens are part of the same path of evolution of DNA-based life on earth, and 
therefore they “must” learn to live with each other. 
This thesis is a written record of this adventure in Tasmania. I hope the reader will see 
how the approach to answer the questions mutates along the chapters and how concepts 
sometimes may cross disciplines. This is my little contribution to better understand our 
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IV.   ABSTRACT 
The Tasmanian devil, the largest living marsupial carnivore, has been threatened with 
extinction because of a rare form of infectious disease, a transmissible cancer known as Devil 
Facial Tumour Disease. The disease emerged in the early 1990’s in the northeast of Tasmania 
and has since spread across 90% of the wild Tasmanian devil range. Fatal in almost 100% of 
cases, DFTD has dramatically impacted devil numbers which have declined more than 90% 
at local scales and more than 80% on average. In this thesis, I apply concepts from host-
pathogen theory to understand the interaction between DFTD and infected devils at the 
individual level. I use field-based empirical and experimental observations in two devil 
populations in the wild to understand the pathogenicity of the cancer and the responses from 
the hosts. By applying host-pathogen theory to this unconventional infectious disease, I 
assess patterns of tolerance and resistance in hosts which I discuss from an evolutionary 
perspective. 
Metabolic and immune condition of devils interact with DFTD infection and 
progression in ways that suggest a level of tolerance and resistance to DFTD. There are 
consistent sex differences across metabolic and immune responses in how devils experience 
and respond to DFTD progression. DFTD increases the metabolic demand on infected 
individuals and may eventually present a constraint on the host energy budget and on the 
tumour itself. This is evident in an overall decline in body condition with tumour progression. 
Sex-differences in tolerance to DFTD are suggested by different rates in decline of body 
condition among the sexes, with body condition of males declining at approximately five 
times the rate of females at a similar cancer burden. Evidence for resistance to DFTD is 
provided by the positive association between the number of antigen-presenting cells in 
tumour tissue and the propensity of tumours to grow more slowly than expected and even to 
fully regress. Males and females also appear to differ in their capacity to respond to infection, 
with sex differences in the relationship between antibodies to DFTD and infection status.  
Analysing the devil-DFTD system within the framework of host-pathogen theory 
helps to understand how this cancer interacts with its hosts. This study provides the first 
evidence of patterns of tolerance to disease progression and resistance against infection by 
DFTD in wild devil populations. The enhanced metabolic rates that infected devils may 
experience is expected to act as a constraint on both tumour and devil physiology, and 
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eventually favour natural selection for slower growing tumours and/or hosts with low 
maintenance costs. The sex differences in devils in tolerance and resistance to DFTD suggest 
both that the selective forces deriving from the infection affect males and females 
differentially, and that the selective forces acting on tumours will depend according to 
whether they are harboured by a male or a female devil.  
The findings of this study have important implications both for the conservation of 
Tasmanian devils and in the broader context of disease and cancer ecology and evolution. 
Although Tasmanian devil populations are still declining as DFTD reaches the last naïve 
populations in the northwest of Tasmania, the species persistence in long-term infected areas 
suggests an ongoing evolutionary process between devils and DFTD. Studies to understand 
the genetic basis of the patterns of tolerance and resistance that are reported here are 
important to inform conservation management. The main conservation strategy implemented 
to date is the maintenance of disease-free populations in captivity and semi-wild on islands 
and fenced reserves to reintroduce individuals into the wild. In this context, the introduction 
of devils from those populations into the wild is expected affect the disease epidemic which 
may eventually dilute local adaptations. The ongoing evolutionary processes between devils 
and DFTD need to be explicitly incorporated into conservation management.  
In a broader context, study of the ecological interactions between hosts and pathogens 
in emerging infectious diseases, such as the devil-DFTD system, provide important insights 
into host and pathogen co/evolution. DFTD is a young disease in evolutionary terms and 
provides the opportunity to observe how host and pathogen evolve on ecological time scales. 
By studying novel host-pathogen interactions under natural conditions in the wild we can 
formulate predictions about evolution of traits, test them and eventually advance theory. One 
of the main limitations in cancer research has been the individual nature of the disease: 
tumours emerge and die within the same organism. This individual-case basis of most cancers 
limits the study and understanding of cancer as a pathogen subject to ecological and 
evolutionary forces. In this context, the capacity of DFTD to be transmissible among hosts 
provides a unique opportunity to study cancer-host evolution in vivo with potential 
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 GENERAL INTRODUCTION 
1.1. Ecology and evolution of host-pathogen interactions. 
Biotic interactions shape life on earth by affecting the ecology and evolution of 
organisms (Benton, 2009). Among all interactions from organismal to population levels, host-
pathogen interactions are the most ubiquitous in space and time (Dobson et al., 2008). 
Organisms are constantly challenged by exposure and potential invasion by pathogens. 
Parasitism as a life form, including organisms with different levels of pathogenicity to their 
hosts, is the most successful and widespread life form on earth including species from all 
kingdoms accounting for approximately 40% of known species. Parasites1 (and 
microparasitic pathogens) are defined as organisms that depend completely or in part of their 
life cycle on resources they extract from their host organisms. In this process, they affect the 
host performance and fitness in a negative way for example by decreasing fecundity or 
increasing mortality rates (Tompkins and Begon, 1999; Hawkins et al., 2006; Robinson et al., 
2010; Finnerty et al., 2017). With their wide distribution and effect on individual hosts, 
parasites have important influence on the ecology and evolution of host populations 
(Combes, 1996; Hudson et al., 1998; Robinson et al., 2010; Hollings et al., 2015). The 
overall effect of pathogen infections on host populations depends on the ecological and 
evolutionary history of the host-pathogen system.  
The epidemiological theory predicts infectious pathogens to become endemic in host 
populations over time, since high mortality of infected hosts will affect the chances of 
persistence of pathogens in the long term. Evolutionary new host-pathogen interactions are 
characterized by important declines of host populations to the point of threatening them with 
extinction (Altizer et al., 2006; Munson et al., 2008; Morley and Lewis, 2014). This epidemic 
pattern of infection outbreaks in naïve host populations is expected to change by natural 
selection operating on the host-pathogen interaction. Thus, long-term interactions can drive 
host-pathogen systems to full dependence and endemicity of hosts by coevolution between 
host and pathogens (Clayton et al., 1999; Webster et al., 2004; Gagneux, 2012). The wide 
1 I use the term parasite and pathogen interchangeably throughout the thesis. 
2 
distribution of host-pathogen interactions in nature suggest that coexistence is a common 
evolutionary outcome. Therefore, persistence of both host and pathogen in the long term will 
depend on the adaptive capacity to respond to natural selection imposed by and on each of 
their interacting populations.   
1.2. Phenotypes at the front line of evolution 
Natural selection acts on phenotypes, with consequences for the underlying gene 
frequency. Thus, phenotypes are at the forefront of natural selection as the success of 
genotypes in passing on their genes to the next generations depends on how well their 
resulting phenotypes perform in the environment the organism experience. The potential for 
evolution in a host-pathogen system will depend on the capacity of pathogen and host 
genotypes to display traits able to respond to selective pressures imposed by the interaction 
(Koella and Restif, 2001; Råberg et al., 2009; Hayward et al., 2014). Three principles are 
required to be met by traits to allow evolution by natural selection  (Darwin, 1859): i) 
Principle of Variation - the trait must present variability between individuals, which means 
that individuals will show different values of the same trait under similar conditions; ii) 
Principle of Differential Fitness - the trait has to covary amongst offspring left by the 
individuals in the population; and iii) Principle of Heredity - the phenotype displayed by an 
individual and its variation is heritable and passed onto the next generation. These principles 
are applicable to the interacting populations of both host and pathogen, and their 
quantification is needed to predict the potential for evolution of the host-pathogen system.  
The ecological interactions and evolutionary processes between pathogens and hosts 
are driven by four main traits: virulence and transmission in the pathogen, and tolerance and 
resistance in the host; both host and pathogen are theoretically expected to favour strategies 
and physiological feedbacks that may allow eventual coexistence based on the interaction of 
the four traits. In the pathogen, natural selection should favour optimal level of virulence to 
allow pathogens to colonize new hosts and replicate within without killing them before 
transmission to a new one (Alizon et al., 2009).  From the host perspective, natural selection 
is expected to favour genotypes which can fight the disease and clear the pathogen from the 
organism (resistance) or genotypes which can buffer the impacts of infection on their fitness 
without limiting the pathogen burden (tolerance) (Råberg et al., 2009). These four traits have 
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adaptive value for both host and pathogen, and their ecological and evolutionary relationship 
will determine the epidemic patterns of the interaction in differential ways. 
1.3. Tolerance to infection 
Tolerance to infection is the host capacity to cope with the infection by buffering the 
costs of it on its fitness (Råberg et al., 2009). The mechanisms of tolerance involve the 
capacity of the host to cope with the direct damage induced by the colonization and 
replication of the pathogen within the host tissues, as well as the capacity of the host to 
restrain its own immune response and reduce “collateral” damage to its own tissues 
(Medzhitov et al., 2012; Soares et al., 2014). An important aspect of tolerance is that it does 
not involve an active attack against the pathogen to restrict replication and therefore does not 
impose a cost on pathogen fitness (Svensson and Råberg, 2010). Tolerance may be visualized 
graphically by plotting the reaction norm of host health against pathogen burden (Simms, 
2000; Råberg et al., 2009; Louie et al., 2016) (Figure 1). The slope of the resultant curve 
indicates the level of host tolerance, a zero slope being a completely tolerant individual and a 
negative infinite slope indicating a completely non-tolerant individual. Hence, the steeper the 
slope, the greater the impacts of pathogen burden on host fitness. Two conceptually different 
curves are obtained by plotting either the health level of different individual hosts at a given 
pathogen burden or by plotting the health level and pathogen burden of different individual 
hosts at different times of infection (Schneider, 2011). The first curve is called a tolerance 
curve, while the second provides a phase or disease curve (Jackson et al., 2014). An 
additional host trait may be derived from this reaction norm: the intercept, which indicates 
the level of health or fitness of the host at a pathogen burden of zero (Råberg et al., 2009). 
This parameter is called host vigour, and its relevance comes when individual hosts present 
with the same level of tolerance (slope) but have different fitness as infection progresses 
(Figure 1-1-B).  
4 
 
The application of tolerance and phase curves in studies of host-pathogen systems in 
wild animals has been limited, for two main reasons: i) difficulty in obtaining repeated 
measures of the same individual host, and ii) difficulty in standardising the pathogen burden. 
While the first issue may be resolved by increasing the intensity of sampling, the second is 
difficult to assess in the context of wild populations. Thus, it is necessary to clarify what is 
meant by tolerance curves measured in the context of studies of wild animal host-pathogen 
systems is required. I propose that tolerance curves may be built from a model that considers 
the pathogen burden as one of the effects, hence a “main effect” curve may be built from the 
model representing the reaction norm of an average individual in the population. Individuals 
whose health measure per pathogen burden falls above the average slope might be considered 
more tolerant than an average individual in the population. In contrast, phase curves are 
applicable to wild populations in their pure concept, being relevant for analysing individual 
responses to infection intensity. 
1.4. Resistance to infection 
Resistance refers to the mechanisms or traits that are expressed by a host once it is 
infected that are intended to clear the pathogen from the organism (Råberg, Graham and 
Read, 2009). Thus, resistance presents direct benefits to the infected host as it reduces 
Figure 1-1 Reaction norm of host health by pathogen burden for two host genotypes. A) Both 
host genotypes H1 and H2 present same level of vigour, but differ in tolerance levels, with H1 
showing higher tolerance than H2. B) Both host genotypes present same level of tolerance but 
different vigour (Adapted from Råberg et al. 2009).    
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pathogen burden and therefore enhances host fitness. Resistance to infection include a range 
of energetically expensive mechanisms from generic behavioural responses, such as 
grooming in the case of lice-infested birds, to specific immunological responses involving 
antibodies that bind to specific targets on the pathogen cell surfaces, such as humoral 
adaptive responses to viral infections. The energetic costs of resistance derive from the 
maintenance and deployment of the activated immune system which trade-off with other 
organic functions (Lochmiller and Deerenberg, 2000; Boots, 2011; Mckean and Lazzaro, 
2011; Husak et al., 2016; Knutie et al., 2017). For instance, the immune-suppressive effects 
of reproductive hormones which mediate a trade-off between defences and reproduction 
(Bonneaud et al., 2003; Cizauskas et al., 2015), may be related to the dependence of both 
processes on the same nutritional budget. While hosts experience costs associated with 
implementing mechanisms of resistance, pathogens carry direct costs to their fitness via 
suppression of reproductive rates. Hosts and pathogens thus both experience selective forces 
to maximize their fitness in infection, resulting in an arms race (Soler et al., 2001; 
Decaestecker et al., 2007). 
1.5. To be or not to be… to tolerate or to resist? 
Both tolerance and resistance involve costs to the host. All biological functions are 
sustained by a limited energetic and time budget, resulting in trade-offs between the two 
strategies during the organism’s lifespan (Svensson and Råberg, 2010). Whether an organism 
will develop tolerance or resistance, or both, will be determined by the fitness costs and gains 
for the host genotype according to the ecological and epidemiological context (Horns and 
Hood, 2012; Knutie et al., 2017). While both strategies may be present in a host population 
(Restif and Koella, 2004), and even in the same individual when tolerance and resistance 
share mechanisms (Mccarville and Ayres, 2018), hosts are expected to express the strategy or 
a combination of both which may provide it with the best cost/benefit balance (Rausher, 
2001; Råberg et al., 2007). It has been proposed that tolerance would be more beneficial 
when the risk of become infected in the host population is high as result of high disease 
prevalence. In this context, the cost of directly fighting the pathogen to decrease its burden 
(resistance) is very high because of the widespread distribution of the disease within the host 
population. The strategy of “learning to live with the enemy” in this context is the less 
expensive tactic (Boots, 2008). Although both tolerance and resistance seek to enhance the 
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fitness of the infected hosts, their evolutionary outcomes for the host-pathogen system differ. 
Resistance positively selects for countermeasures from the pathogen, perpetuating an arms 
race between host and pathogen. On the other hand, the evolution of tolerance may direct the 
host-pathogen interaction towards stable evolutionary dynamics (Roy and Kirchner, 2000; 
Best et al., 2014). This likely outcome is based on the concept that a tolerant host increases 
the infectious period by living longer once infected, allowing disease prevalence to increase 
and thus enhancing the benefit of carrying tolerance genes. Additionally, the pathogen might 
decrease its virulence as a result of a longer infectious period, representing a positive 
feedback on host tolerance. Another benefit for tolerant host genotypes is that pathogens may 
be more virulent in non-tolerant hosts, and therefore reduce intraspecific competition in the 
host population. This dynamic would drive the whole host-pathogen system, theoretically to a 
commensal interaction, allowing the coexistence of both host and pathogen (Best et al., 
2014). The impacts of tolerance, however, are not unidirectional since an increase in survival 
of infected individuals may increase the chances of co-infection by multiple pathogen 
genotypes, which would increase competition among them, selecting for higher virulence 
(Susi and Laine, 2017). 
1.6. The Tasmanian devil and its transmissible cancer as study case 
The Tasmanian devil, a marsupial carnivore endemic to the island of Tasmania, has 
suffered dramatic population declines during the past 20 – 25 years. The cause is a new 
pathogen, a transmissible cancer called Devil Facial Tumour Disease (DFTD) (Pearse and 
Swift, 2006; Pye et al., 2015). The first signs of devils infected with DFTD were detected in 
the north-east corner of Tasmania in 1996, and since then the disease has spread across the 
island decimating devil populations to the point that extinction was posited as a possible 
outcome  (McCallum et al., 2009). Molecular analyses revealed that DFTD originated in glial 
cells from a female individual devil (Murchison et al., 2010).   
Transmissible cancers are considered to be a rare form of infectious disease (Pearse 
and Swift, 2006; Metzger and Goff, 2016). Transmissible cancers differ from other infectious 
diseases in their aetiology, in that the infectious agent are the tumour cells themselves, which 
are able to be transmitted among susceptible hosts by close contact (Metzger and Goff, 2016) 
as allographs or transplants. In this process, for the cancer to become transmissible, at least 
7 
 
two conditions need to be met: i) inoculation of infective cells from an infected to a 
susceptible host, and ii) prevention of immune rejection from the new host. Inoculation of 
DFTD cells from infected to susceptible devils occurs by direct contact during agonistic 
interactions, including potentially devils receiving bites from tumour-laden canine teeth or 
devils biting into the tumours of others. Contact rates of devils increase during the mating 
season, when individuals bite each other more frequently, and potentially the main period of 
disease transmission (Pearse and Swift, 2006; Hamede et al., 2008, 2013; Hamilton et al., 
2019). Once an individual is inoculated, immune rejection may be prevented as a 
consequence of multiple factors acting in conjunction: i) Low genetic diversity of devils. 
Devils present low diversity in alleles of the major histocompatibility complex, which 
increases the probability of tissue compatibility among individuals (Siddle et al., 2007). ii) 
Modulation of antigenic molecules on the tumour surface. Tumour cells down-regulate 
MHC molecules on their surface (Siddle and Kaufman, 2013) preventing immune recognition 
by the host immune system. Under normal conditions, MHC molecules are crucial in self-
recognition, thus when molecules on cell surfaces do not match those of the host, an immune 
response is triggered against the foreign tissue. The loss of antigens on the cell surface may 
be consequence of natural selection acting on the generation of “tumour escape” phenotypes 
(Khong and Restifo, 2002) at early stages of disease emergence. iii) Ontogenic changes in 
immune condition of hosts. Ratios between IgG and IgM, indicative of changes from 
generic to induced humoral responses in mammals change with sexual maturity in devils 
(Ujvari et al., 2016). Similar patterns, have been described for cancer-related immune 
surveillance (Cheng et al., 2017). These findings have been hypothesized as causative of 
detection of DFTD almost exclusively in sexually mature individuals, and not in juveniles 
before puberty.        
At the individual level, disease progression drives its host to death in almost 100% of 
cases, however details about the pathogeny and pathology of disease progression are sparse. 
DFTD infection in hosts is characterised by the appearance of growing masses of tissue on 
the oral surfaces, head and neck region of Tasmanian devils. Tumour tissues usually present 
with ulceration through the skin or mucosal tissues which is susceptible to contamination by 
bacteria with the consequent infection. Once clinical signs of infection are evident, host death 
occurs within 6-12 months. Mortality has been proposed to be a consequence of the 
compromised general physiological condition of hosts by three main mechanisms as the 
disease progresses: 1) metastasis, 2) starvation, and 3) secondary complications (Pyecroft et 
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al., 2007). Metastasis occurs in approximately 65% of cases, compromising mainly lungs and 
spleen (Loh et al., 2006), however, timing and likelihood of metastasis are aspects of the pathophysiology of DFTD that remain 
unclear. Starvation would take place when tumour location negatively affects the feeding 
behaviour either mechanically or chemically by releasing tumour toxins inducing anorexia. 
Secondary complications, such as bacterial or parasitic opportunistic infections, take place on 
the tumour tissue which acts as an open wound or because of immune compromise. These 
three conditions are not independent from each other and can function simultaneously and in 
synergy in the same individual host.  
DFTD outbreaks follow similar trends in devil populations across its distributional 
range, with catastrophic effects on the abundance of the host population. The high mortality 
and apparent 100% of susceptibility inferred from demographic data translate to a decline in 
absolute devil numbers and changes in age structure 5 – 6 years after disease arrival (Lachish 
et al., 2007). Based on these parameters, epidemiological and mathematical models suggested 
that extinction of infected devil populations in the wild was a possibility (McCallum et al., 
2009). Populations have persisted at low numbers in long infected areas, however (Lazenby 
et al., 2018).This failure of the early models to predict the mid- and long-term demographic 
patterns of outbreaks could be a consequence of limited data from a single study site, lack of 
sophistication in the models (Wells et al., 2018), or from individual heterogeneities in 
tolerance and/or resistance against the disease, and/or changes in virulence and transmission 
ability of tumours. Hamede et al. (2011) provided some of the earliest evidence of differential 
impacts of the disease in a population at the epidemic front in northwest Tasmania. The 
decline of devil numbers after disease arrival was slower than it was in populations further 
east. The differential epidemiological pattern in the same population has been linked to 
changes in the predominant tumour lineage, thus tetraploid tumours seem to be related to 
slower impacts on the population, while diploid tumours may be more prevalent in advanced 
stages of the outbreak inducing the collapse of the age structure in the population (R. Hamede 
et al., 2015). As consequence of the clonal nature of tumours the evolution of diverse 
lineages may be driven by epigenetic mechanisms, while phenotypic plasticity and genetic 




1.7. Signs of evolution in devils 
Newly emergent pathogens represent strong selective forces for evolution by natural 
selection on host populations. High mortalities in naïve host populations follow epidemics by 
emergent pathogens and increase the natural rate of remotion of genotypes from the host 
populations, and therefore the selective pressures acting on them. In situations where there is 
a lack of phenotypic variability among hosts, the host population is expected to be driven to 
extinction as a consequence of its incapacity to adapt (Schloegel et al., 2006). However, 
when heterogeneity in host susceptibility, tolerance or resistance to the new pathogens are 
present is present among hosts and there is a genetic basis to this variability, this process may 
result in an increase in the frequency of rare genotypes following the epidemic. This change 
in frequency of genotypes in host populations has been highlighted as key in allowing host 
populations to persist in the long term, by changing the “affinity” or matching between host 
and pathogen genotypes. In the case of the devil-DFTD system, the disease represents an 
extremely strong selective pressure on the devil populations because it removes up to 100% 
of the adult age classes which represent approximately 80% of the local populations. The 
strongly frequency-dependent transmission of the disease, in addition to an apparent 100% 
susceptibility of individual devils (Lachish et al., 2007; McCallum et al., 2009), 
hypothetically places DFTD, in the spectrum of selection strengths of pathogens on their 
hosts, as a case of very high selection on its devil host populations. 
In the 20-25 years since the emergence of DFTD, this relatively new interaction, in 
evolutionary terms, between Tasmanian devils and their facial tumours has already shown 
signs of a rapid evolutionary response. In a first study attending the effects of DFTD in the 
genetic structure of devil populations, Lachish et al., (2011) describe no changes in genetic 
diversity within populations, but differentiation among populations attributable to disease 
outbreak. In a genome-wide approach, disease outbreaks have been linked to changes in two 
regions of the devil genome (Epstein et al., 2016). These regions include seven candidate 
genes involved in cancer and immune related functions. In a more recent study, (Hubert et 
al., 2018) re-analysed the data set published by Epstein et al. (2016) finding 92 signatures of 
selection in the devil genome, including the same candidate genes identified by the previous 
studies, but also genes related to behavioural and cancer traits. A third study tried for the first 
time to link genomic information with phenotypic traits, the authors found sex differences in 
the capacity of the variability in SNPs to explain survival in infected individuals, with a much 
10 
 
greater explained deviance in females than male devils (Margres et al., 2018). Two 
remarkable aspects of these findings are important to highlight. First is that the evolutionary 
response has been incredibly rapid, occurring in as little as 4-6 generations following local 
disease outbreak (Epstein et al., 2016; Hubert et al., 2018). This is much faster, for example, 
than evolution of European rabbits to the introduction of the Myxoma virus as a biocontrol 
agent in Australia, which is one of the classic cases of host—pathogen coevolution (Kerr et 
al., 2015). Second, evolution has occurred on standing genetic variation, which is apparently 
sufficient (Epstein et al., 2016; Margres et al., 2018) regardless of the low genetic variability 
described in devils (Jones et al., 2004; Morris et al., 2013), which was thought to restrict their 
adaptive capacity (Pearse et al., 2012)   
1.8. Signs of evolution in tumours 
The evolution of the devil facial tumours is expected to be much more restricted than 
evolution in the devil host as a consequence of its clonal nature. DFTD originated in mutated 
Schwann cells from a single female devil in the early 1990’s in north-east Tasmania 
(Murchison et al., 2010). Since its emergence, the tumour cells have replicated by clonal 
reproduction and passed from host to host. This clonal replication of tumours represents two 
major constraints for its evolution, i) intrinsic low variability among tumours (all of them 
have their origin in the same cell), and limited evolution potential by genomic changes. These 
two conditions mean that evolution in the tumour is more likely to be driven by epigenetic 
change than by changes in the genome (Ujvari et al., 2013). Despite these intrinsic 
evolutionary constraints imposed by the nature of tumours, however, different lineages have 
been detected (Murchison et al., 2012; Pearse et al., 2012) with potential functional impacts 
on the epidemiological patterns of the disease (Hamede et al., 2015). 
Evolution of pathogens is expected to be faster than in their hosts because 
microparasitic pathogens have much faster intergenerational times. In the case of DFTD, 
however, evolution in tumours is expected to take place at a slower rate than in hosts as a 
consequence of their highly stable genome (Deakin et al., 2012), and the epidemiological 
patterns of infection (Lachish et al., 2007; McCallum et al., 2007). When the disease arrives 
into a naïve devil population, the hosts are immediately under selection pressure, as the 
infection drives them to death. However, the pressure for tumours to evolve differs in its 
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temporal and mechanistic dynamic according to the epidemiological context (Hamede et al., 
2015). Thus, when susceptible hosts are abundant and disease prevalence is low, the force of 
selection on tumours is expected to be low. As disease prevalence increases, and therefore 
multiple tumours are transmitted to a naïve host by independent contacts with multiple 
infected hosts, selection on tumours may be driven by competition among them; later on, as 
host availability decreases, selection on tumours is expected to be driven by survival of 
infected hosts which depends on tumour virulence and host tolerance. Although, these 
potential mechanisms have not been explicitly tested in the devil-DFTD system, there is 
evidence supporting their occurrence as different tumour variants diverge as the disease 
continues spreading across devil populations. Murchison et al., (2012) described divergences 
of tumour lineages based on mitochondrial DNA, with specific lineages associated to 
restricted geographical areas potentially emerged by selective pressures. In a second study, 
based on cytogenetic analyses the authors reported five different tumours strains based on 
their karyotype arrangements (Pearse et al., 2012). Changes in the prevalence of diploid and 
tetraploid strains were reported in south-east Tasmania after removal of infected devils in an 
effort to decrease the spread of the disease in the population (Ujvari et al., 2014). In a later 
study, Hamede et al. (2015) presented the first evidence of potential epidemic patterns 
following lineage replacement (diploid vs tetraploid) in one population of devils in north-
west Tasmania. Further evidence of tumour evolution from an epigenetic perspective suggest 
that changes in patterns of methylation of the DNA may play a role in the evolution of 
tumours (Ujvari et al., 2013). Finally, all the available evidence, supports the view that 
regardless its clonal replication, DFTD may compensate the lack of genetic-driven adaptive 




1.9. Thesis aims and outline 
As I have described above, signs of evolution in both host and pathogen are emerging 
as the interaction between devils and tumours progresses in time and space. The underlying 
mechanisms of evolution may be intrinsically different in devils and tumours; however, it has 
been well established that both, host and pathogen are under selective pressure. Despite this, 
there is limited evidence of variability in the phenotypes of the devil-tumour interaction on 
which natural selection may act. Immune condition of devils, and specific responses against 
DFTD at the individual level have been studied, but there is a lack of studies on devil traits in 
the context of host-pathogen ecological and evolutionary theory. In particular, no studies to 
date have explored differences in patterns of tolerance and resistance to DFTD at the 
individual and population levels.  
The main aim of this thesis is to explore patterns of phenotypic interaction between 
the Tasmanian devil and its transmissible cancer in an ecological and evolutionary 
perspective. I address this aim by formulating specific questions to understand how the devil 
physiology relates to cancer progression (Chapters 2 – 5). I present my ecological results in 
an evolutionary outlook discussing them under the context of how the extended phenotype of 
devil-cancer interaction might drive the evolution of tolerance and/or resistance to the disease 
in devils. Finally (Chapter 6), I identify the caveats of this work and present some 
perspectives for future research from a phenotypic perspective to understand the functional 
biology of devils and tumours in the long-term and test predictions of selection in natural 
populations. 
In chapter two I assess the dynamic of white blood cell counts of wild Tasmanian 
devils. By using a model selection approach, I assess the importance of intrinsic and extrinsic 
variables influencing total white blood cell counts in devils. The results show differences 
between male and females devils and a non-linear relationship between the white blood cell 
counts and disease progression.  
In chapter three I explore a dimension of the cancer pathogenicity not considered in 
previous research: the influence of infection in field metabolic rates of wild devils. I 
performed field experiments using the doubly labelled water technique to assess how the 
energy expenditure of infected devils changed in comparison to healthy individuals in natural 
conditions. The results of this chapter contributed additional information about how the 
13 
 
cancer can impose restrictions to the energetic budget of devils and therefore compromise 
their performance and fitness in the wild. 
 In chapter four I test the general effect of cancer infection on general condition and 
physiology of hosts. I used the reaction norm of host body condition as proxies of health by 
pathogen burden to build tolerance curves at the population level. My results represent the 
first attempt to evaluate tolerance to cancer in Tasmanian devils and one of the very few 
studies assessing natural variation of tolerance to disease in natural host populations.  
In chapter five I investigate signs of resistance against DFTD in devils at the 
population level. Specifically, I assess how the devil immune system may be influenced by or 
may influence the disease progression. To do so, I evaluate seasonal changes in innate and 
induced immune condition of healthy and diseased devils, and their relation to disease 
progression. In addition, I present information about immune context that may lead devils to 
recover from the infection and develop resistance by analysing in depth cases of naturally 
recovered devils. I discuss these results in the context of the evolution of tolerance and 
resistance against the cancer in the devil population and their potential consequences for the 
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  DYNAMIC OF TOTAL WHITE BLOOD 
CELL COUNTS IN WILD TASMANIAN DEVILS 
2.1.  Introduction 
Organisms are constantly challenged by environmental conditions, and internal and 
external pathogens which influence their physiology and eventually their performance and 
fitness. The ecological pressure that pathogens represent for hosts have favoured the 
evolution of defensive strategies leading eventually to the development of the highly 
specialized immune system (Tschirren and Richner, 2006). Since pathogens are ubiquitous, 
the immune system is crucial for host fitness. Immune function commonly trades-off with 
other fitness components, such as reproduction and even counterintuitively survival (Moret 
and Schmid-Hempel, 2000; Husak et al., 2016; Schwenke et al., 2016). This compromise 
between immune condition of hosts and other components of fitness derives from the 
energetic costs associated with maintaining the cellular and molecular components of the 
immune system according to varying availability of resources and physiological “priorities” 
through the lifespan of organisms (Nelson and Demas, 1996; Nelson, 2004; Korfel et al., 
2015; Strandin et al., 2018). As a result, the immune system can be highly affected by 
ontogenetic development, reproductive investment and overall energy availability among 
other dynamic factors, which ultimately translate to a heterogenous risk of infection within 
and among host populations (Altizer et al., 2006). 
White blood cells (WBCs) are the basic unit of the immune system, and which carry 
out a range of innate and adaptive immune responses. Also called leukocytes, from the greek 
leuk = white and cyt = cell, white blood cells lack the internal molecules that confer colour 
such as the case of haemoglobin in red blood cells. The total number of WBCs in a sample 
count is a useful generic indicator of an organism’s immune competence, even though the 
WBCs are composed of different types, which relate to different components of the immune 
response (Beldomenico et al., 2008a). Thus, the number of leucocytes circulating in blood is 
a basic and informative parameter used in veterinary medicine to assess the health status of 
vertebrates in generic terms (Maceda-Veiga et al., 2015). Changes in WBC counts outside of 
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the reference intervals for a species will suggest clinical implications related to poor 
condition (low numbers) or reaction to infection (high numbers) (Beldomenico et al., 2008b, 
2009). Understanding how WBCs naturally change in wild populations in health and disease 
states is part of the basic knowledge to inform actions for wildlife health management 
(Beldomenico et al., 2008a, 2009; Lazzaro and Little, 2009; Maceda-Veiga et al., 2015; Peck 
et al., 2016). Baseline knowledge is particularly important in the case of emergent infectious 
diseases (EIDs), because EIDs are important drivers of population declines in wildlife and are 
therefore of conservation concern (Daszak et al., 1999; Aguirre and Tabor, 2008; Frick et al., 
2010; Graystock et al., 2013). In this chapter, I assess how WBCs numbers in Tasmanian 
devils change in healthy individuals and individuals infected by a novel transmissible cancer 
(devil facial tumour disease; DFTD).  
The Tasmanian devil, which is the largest extant marsupial carnivore on earth, has 
been at placed at risk of extinction as its numbers decline with the spread of DFTD (Hawkins 
et al., 2006; McCallum et al., 2007; Grueber et al., 2018; Lazenby et al., 2018). The 
transmissible cancer was detected for the first time in an individual devil in the north-east of 
Tasmania in 1996. DFTD was established as a transmissible cancer based on cytogenetic 
similarity among tumours in different hosts (Pearse and Swift, 2006). Its origin was 
determined as from Schwann cells of a female devil in the early 1990’s (Murchison et al., 
2010). Transmission most likely occurs during injurious biting, which peaks during the 
mating season in late summer and early autumn (Hamede et al., 2008). Agonistic interactions 
during the mating season involve male—male competition for females and intensive mate 
guarding of females by males during their oestrus, a process that can result in injury to both 
sexes (Hamede et al., 2008, 2013). Biting behaviour increases the risk of infection due to 
contact between open wounds and tumour cells, either by inoculation of cancer cells on teeth 
of infected individuals or by animals biting into the tumour of another devil. Devils 
frequently have wounds inside their mouth and around the oral region (Hamede et al., 2013). 
In addition to enhanced injurious biting, the reproductive season is a stressful time for both 
sexes, and particularly for males which lose 25% of their body weight (Jones et al., 2008). 
High and sustained stress levels during the mating season may compromise the immune 
competence of devils, and act in synergy to increase the risk of establishment of tumour cells 
transferred to a new host. Studies exploring the natural variation of immunity in wild devils 
are sparse, reference intervals for the species have recently been published (Peck et al., 
2015).  
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We first explore the influence of ecological variables on the total white blood cell 
counts of wild Tasmanian devils. Using two modelling approaches based on linear mixed 
models and generalized additive mixed models, we assess the nature of the relationship 
between intrinsic and extrinsic variables and the WBC of devils. Second, we present the 
relationship between the progression of infection with DFTD and total WBC counts and 
hypothesise how the immune competence of individual hosts may be both the cause and the 
consequence of health status of Tasmanian devils.  
2.2. Methods 
2.2.1. Field data and sample collection 
Two study sites of 25 km2 each were established in northwest Tasmania, Australia, in 
the localities of West Takone (379369 E / 6440624 S) and Wilmot (426417 E / 5414182 S). 
The devil populations at the two sites were sampled at three-month intervals, between 
February 2015 and 2017 (February 2016 was not conducted), to address seasonal and 
physiological changes associated with reproduction. The resulting data set comprised 12 
trapping sessions for the Takone site, and 8 sessions for Wilmot. Each field session consisted 
of 10 continuous days of trapping in which 40 custom-built carnivore traps were deployed. 
Upon first capture, each individual devil was permanently marked with a subcutaneous 
microchip, and sex and age (using tooth wear, accurate to 3 of 5 years lifespan) were 
determined. Body mass and head width (maximum width across the zygomatic arch), as a 
linear measurement of skeletal size, were recorded. Head width was also used as a continuous 
indicator of temporal and physiological age. For individuals presenting with clinical signs of 
infection with DFTD, a photo-identification of individual tumours was captured, and the 
maximum length, width and depth of tumours measured, volume being calculated later using 
the formula for ellipsoid volume. Infected devils often presented with more than one tumour 
in different locations on the body at the same time. In these cases, total tumour volume was 
calculated by summing the volumes of all tumours present in the host at the time of 
observation. A body condition index was calculated from the allometric relationship between 
body mass and head width (Ruiz-Aravena et al., 2018).  
Blood samples to perform white cell counts were collected from ear veins. 200 ul of 
blood were collected in EDTA by puncture of the ear vein with a hypodermic needle. White 
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blood cell counts were performed in a Neubauer chamber within 10 hours from sample 
collection. 50 ul of blood were diluted in 950ul of crystal violet (0.2%). The total number of 
cells were counted in five large squares of the Neubauer chamber, and then divided by 5 to 
perform calculation of number of cells per ml of whole blood.  
2.2.2. Statistical analyses 
We evaluated the relative influence of external and intrinsic variables on the total 
counts of WBCs in Tasmanian devils by using linear mixed effects models (LMM) and 
generalized additive mixed models (GAMM) to account for non-linear relationships among 
variables. In both analyses, we applied a model selection approach to discard variables with 
limited explanatory capacity. In the case of LMM, the model selection was performed based 
on the AIC values obtained for different model formulations. In the case of the GAMM, we 
formulated the same models used in the LMM framework and conducted a slightly different 
approach for model selection based on AIC used for the LMM. The GAMM formulation 
allows for penalization of the smooth terms included in the model which allows shrinking of 
the smooth term to zero if the term does not contribute to the model. In this way, if a variable 
has effective degrees of freedom approximating zero, the model is refitted without that 
smooth term. On the other hand, values of effective degrees of freedom also help assess the 
nature of the relationship among variables. Values close to 1 support a linear relationship 
between variables while values above 1 suggest a strong non-linear relationship.  
The response variable (white blood cell counts) was log-transformed to meet 
normality assumptions. Therefore, I used a Gaussian error distribution in both, the LMM and 
GAMM formulations was used. Predictor variables in both LMM and GAMM included: 
individual sex, head width as a proxy of body size and age, total tumour volume in mm3, ratio 
between total tumour weight and body weight (T/B), body condition, and day of the year as a 
proxy for seasonality. Day of the year was modelled as angles to account for circularity of the 
variable. The two-way interaction terms between sex and the rest of the variables were also 
included as predictors, to account for intrinsic physiological differences between sexes that 
may influence the WBC numbers (e.g. endocrine profiles) (Pennell et al., 2012; Roved et al., 
2017). Tumour burden was included in the models as either total tumour volume or T/B 
avoiding including both due to their correlation. Finally, individual devil ID was included as 
a random effect to account for non-independence of observations derived from multiple 
24 
measures from the same individual. All statistical analyses were conducted in the R 
environment, using the libraries “nlme” and “mgcv” for the LMM and GAMM, respectively. 
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2.3. Results 
A total of 247 individual values for white blood cell counts from 151 individual 
Tasmanian devils were included in the analyses. The data included observations collected 
between November 2015 and May 2017. Overall, 41 observations (16.59%) fell outside the 
reference intervals described for wild Tasmanian devils by Peck et al. (2015). Of those 41 
observations, 56.09% were recorded in individuals without clinical signs of infection by 
DFTD. No sex bias was evidenced among the 35 individuals presenting leucocytosis (WBC 
above the reference interval) (χ2 = 0.14, df = 1, p =0.7). In contrast, all the individuals with 
leukopenia (n = 6) were females (Figure 2-1 and 2-2).    
The best LMM formulation (delta AIC <2) explaining white blood cell counts 
included the variables head width and the ratio between tumour and body weight (Table 2-1) 
and explained 24.7% of the null deviance. The total number of white blood cells declined 
with increasing head width (Figure 2-1A). T/B showed an opposite relationship, with white 
blood cell counts increasing with T/B (Figure 2-1B).     
The GAMM formulations performed better than the LMM in their explanatory 
capacity of the data. The GAMM with most support presented an AIC 9.67 unit lower than 
the most supported LMM formulation and accounted for 42.7% of the null deviance, 
contrasting the 24.7% from the best LMM. This better performance of the GAMM over the 
LMM formulations suggests strong non-linearities in the relationship between the variables. 
The selection of smooth terms by shrinkage identified head width, T/B, and the interactions 
of sex and day of the year and sex with body condition as the most important explanatory 
variables (Table 2-2). Head width presented an almost linear negative relationship with white 
blood cells (Figure 2-2A). In contrast, T/B presented a non-linear saturating curve 
relationship (Figure 2-2B) with WBC increasing as the tumour weight relative to body weight 
increased. The relationship of body condition and day of the year with cell counts varied with 
sex. Body condition was associated with WBC only in females and was linear, in contrast to 
males in which there was no relationship (Figure 2-2C). Day of the year presented a slightly 
declining non-linear relationship to WBC in females, while in males there was no relationship 
of day of year with WBC (Figure 2-2D).  
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Table 2-1 Results of the model selection on Linear Mixed Model formulation for total white 
blood cells in wild Tasmanian devils. 
Estimated coefficients from the full and most supported model formulations are shown under 
the column “terms”. AIC is the Akaike information criterion, and D2 is the percentage of 
explained deviance. WBC = white blood cell count, HW = head width, Tvol = total tumour 
volume in mm3 (log-transformed), T/B = ratio between total tumour weight and body weight, 
SexM = sex (male), BC= body condition, Day = day of the year.    
Predictor Full Model Best model 
Estimate SE Estimate SE 
Intercept 9.575   1.205 8.969 0.688 
HW -1.220 0.602 -0.908 0.341
Tvol 0.008 0.008 - - 
T/B 14.853 3.700 17.939 2.133 
SexM -0.143 1.713 - - 
BC -0.322 0.135 - - 
Day -0.039 0.016 - - 
HW:SexM 0.088 0.851 - - 
BC:SexM 0.331 0.189 - - 
Tvol:SexM -0.001 0.013 - - 
T/B:SexM 1.731 5.638 - - 
Day:SexM 0.026 0.025 - - 
AIC -223.28 -258.07
Deviance 19.7 24.7
Figure 2-1 Relationship between white blood cell counts and head width (A) and white blood 
cell counts and the ratio between total tumour weight and body weight (B) estimated from the 
most supported LMM formulation. Points in plots represent observations for males (green 
triangles), and females (red circles). Red dashed lines represent the reference intervals 
described by Peck et.al. (2015) for total white blood cell counts in wild Tasmanian devils. 
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Table 2-2 Results of the model selection on Generalized Additive Mixed Model formulation 










Estimated smooth terms from the full and most supported model formulations are shown 
under the column “terms”. Si represents the cubic regression spline for the respective 
variable, df are the effective degrees of freedom, AIC is the Akaike information criterion, and 
D2 is the percentage of explained deviance. WBC = white blood cell count, HW = head 
width, Tvol = total tumour volume in mm3 (log-transformed), T/B = ratio between total 
tumour weight and body weight, SexM = sex (male), SexF = sex (female), BC= body 









Predictor Full Model Best Model 
Estimate SE edf Estimate SE edf 
Intercept 7.142    0.013 - 7.146    0.013 - 
s(HW) - - 1.371 - - 1.266 
s(Tvol) - - ≈ 0 - - - 
s(T/B) - - 2.575 - - 2.451 
SexM 0.039 0.020 - 0.032 0.020 - 
s(BC) - - ≈ 0 - - - 
s(Day) - - ≈ 0 - - - 
s(HW) : SexM - - ≈ 0 - - - 
s(HW) : SexF - - ≈ 0 - - - 
s(BC) : SexM - - ≈ 0 - - ≈ 0 
s(BC) : SexF - - 0.790 - - 0.864 
s(Tvol) : SexM - - ≈ 0 - - - 
s(Tvol) : SexF - - ≈ 0 - - - 
s(T/B) : SexM - - ≈ 0 - - - 
s(T/B) : SexF - - ≈ 0 - - - 
s(Day) : SexM - - ≈ 0 - - ≈ 0 
s(Day) : SexF - - 1.673 - - 1.673 
AIC -265.26 -267.49 
Deviance 41.0 42.7 
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Figure 2-2 Relationship between white blood cell counts and predictor variables estimated 
by the most supported GAMM formulation. A) head width, B) ratio between total tumour 
weight and body weight, C) Body condition by sex and, D) Day of the year by sex. Points in 
plots represent observations for males (green triangles), and females (red circles). Red 
dashed lines represent the reference intervals described by Peck et.al. 2015 for total white 
blood cell counts in wild Tasmanian devils. 
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2.4. Discussion 
We present an evaluation of the importance of intrinsic and extrinsic factors 
influencing the total number of white blood cells in wild Tasmanian devils. The 
methodological approach applied shows that white blood cell numbers in wild Tasmanian 
devils are influenced by internal devil attributes (e.g. sex), environmental conditions (e.g. 
seasonality) and by the interaction of individual devils and the recently emerged transmissible 
cancer, the devil facial tumour disease (DFTD). The results show that white blood cell counts 
of wild devils decrease with age in both males and females but follows different seasonal 
patterns in each sex. In females, WBCs increase to a peak in early winter and then decrease 
through spring and summer into autumn. Males do not experience changes in white blood cell 
counts through the year. Differences between the sexes were detected also in the relationship 
between body condition and cell counts. There was almost no relationship in males, while in 
females the number of cells decreases as body condition increases. Finally, there is a strong 
non-linear relationship between white blood cell counts and the ratio of tumour and body 
weight, with and overall increase in cell counts as T/B increases. These findings support the 
idea that the immune status of wild Tasmanian devils is dynamic and influenced by 
environmental and physiological conditions.  
Total white blood cell counts in devils show a general decline with age (head width) 
in consistency with previous studies in captive (Hope and Peck, 2016; Stannard et al., 2016) 
and wild Tasmanian devils. This pattern may not have clinical implications for health as the 
total range in white cell numbers between the smallest and largest devils (head width) was 
within the reference intervals for the species (Peck et al., 2015), however it highlights the 
need for stablishing differential reference values for different age classes. The pattern One 
potential explanation for the decline of WBC as skeletal size of individuals increases might 
be trade-offs associated with ontogenetic stage in energetic investment in immune function, 
growth and reproduction or effects of senescence (Norris and Evans, 2000; Valtonen et al., 
2010; Schwenke et al., 2016).  
White cell counts increase with pathogen load (tumour to body weight ratio) in both 
model types (LMM, GAMM), but the GAMM formulation showed non-linear detail in the 
pattern of response with increasing pathogen load. There was a sharper increase in the 
number of white blood cells in the early stages of infection, when tumour weight represents 
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approximately 1% of the body weight of the infected devil in consistency with previous 
studies (Peck et al., 2016). During this early phase of infection, WBCc reach levels above the 
upper limit of the reference intervals for the species, indicating leucocytosis. This increase in 
the number of WBC is expected to be related to the progression of DFTD as previous studies 
did not find differences between healthy individuals and devils with wounds, however DFTD 
infected devils presented significantly higher number of neutrophils. The higher WBC counts 
as tumour burden increases,  may be driven initially by the damage of host tissues from 
mechanical invasion by DFTD tissues, and at late stages, by secondary bacterial colonization 
of ulcerated tumours (Loh et al., 2006; Peck et al., 2016).  
GAMM formulations performed better in capturing the relationship between WBC 
and body condition of devils and seasonality. Day of the year and body condition, and their 
interactions with sex, were part of the final GAMM structure. For body condition, the 
GAMM did not show a relationship with WBC in males, while in females it did. Two 
potential explanations may be drawn from the negative relationship between WBC and body 
condition of females, although this response is not expected to have clinical relevance for 
individual health as the values fall within the reference intervals described for the species. 
First, if body condition is mainly driven by exposure to pathogens, individuals with high 
body condition may be less exposed to infections, and therefore WBC numbers maintain low 
(Debeffe et al., 2016). Another potential explanation rises if body condition positively 
correlates with other fitness components that trade-off with immunity (Husak et al., 2016). 
For instance, individuals in better body condition may invest more in reproduction, which has 
been largely documented to have immune-suppressor effects, and therefore present lower 
WBC counts (Trigunaite et al., 2015; Schwenke et al., 2016). Sex differences were also 
detected in how WBC numbers vary along the year. WBC in females varied significantly 
throughout the year with the lowest level in early autumn, then highest in early winter. This 
pattern in females is likely to reflect reproductive investment and may be mainly driven by 
changes in the number of circulating neutrophils as previously reported (Peck et al., 2015). 
Mating season in devils takes place in late summer and early autumn, females experience low 
costs during pregnancy and early stages of young in the pouch, which substantially increase 
as denned young grow faster towards independence in early summer. In contrast to females, 
reproductive patterns in male devils do not seem to be seasonally driven (Keeley et al., 2012), 
and therefore they may not experience important variation in the costs of maintenance along 
the year, which explain the lack of seasonality in their WBC numbers, however this findings 
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contrast with previous studies that report seasonal changes in WBC in adult males. One 
potential explanation for this contrasting findings is the methodological differences in the 
treatment of season as factor in the study by  Peck et al., (2015) or as a continuous variable in 
this study. 
Maintenance and deployment of a competent immune system is an expensive 
condition for organisms, but also critical for survival (Lochmiller and Deerenberg, 2000; 
Bonneaud et al., 2003; Beldomenico et al., 2008b). Both phenotypic and genetic costs that 
influence physiological trade-offs have been proposed and demonstrated to be present when 
immune activation takes place (Promislow and Harvey, 1990; Martin et al., 2003, 2008). 
These costs are related, for instance, with increased metabolic activity by immune cells, 
altered priorities for energy allocation, and damage in host tissues if there is exacerbated or 
uncontrolled immune activation. The magnitude of seasonal variation experienced by female 
devils represents a change of approximately 8x10^7 cells x ml-1 which equals to 40 – 50% the 
normal number of white blood cells in a healthy individual. Thus, in a scenario where 
defences are energetically and ecologically expensive, and investment on them depends upon 
other expenses such as reproduction, it is possible to suggest that seasonality in female devils 
might have a cost equivalent to 50% of their energetic budget for defences, however this 
costs may be different if the changes in number of cells are compensated by other 
components of the immune system (Jackson et al., 2011; Gilot-Fromont et al., 2012). Further 
studies including indicators of the innate and adaptive branches of the immune system are 
required in order to understand overall changes in the immune condition of Tasmanian devils 
in the wild.      
The sex differences found in the relationships between WBC and both body condition 
and seasonality indicate that male and female devils may experience the environment 
differently influencing their physiology. Because of this, the costs of immunity and therefore 
the defensive strategies such as tolerance and resistance to infections are expected to vary 
between males and females. Evidence of differences between male and female devils is 
consistent across multiple analytical approaches. Sex bias in the levels of tolerance to DFTD 
have been recently reported, with females presenting patterns of higher tolerance than males. 
At the genomic level, female survival and potentially resistance to cancer has been linked to 
variability in the genome (Margres et al., 2018). Finally, sex differences suggesting that the 
antigenicity of DFTD may be different in males and females confirm that the immune 
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response against the cancer varies between the sexes (Chapter 5). This combined evidence 
suggests that the host-pathogen interactions should vary in outcome according to whether a 
pathogen is harboured by a male or a female devil. This, in turn, is expected to differentially 
drive the evolutionary interactions between host and pathogen and to potentially be a source 
of divergent sex-biased defensive strategies (Roved et al., 2017).  
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 THE METABOLIC COST OF CANCER 
IN THE ENDANGERED TASMANIAN DEVIL 
3.1. Introduction 
Emerging infectious diseases are recognised as a major threat to biodiversity (Daszak 
et al., 2000; Cunningham et al. 2017). Although viruses and bacteria are thought of as the 
main pathogens of concern in wildlife conservation (Daszak et al, 2000; Smith et al, 2009; 
Frick et al , 2010; Kilpatrick et al, 2010; Robinson et al, 2010), other non-traditional 
diseases, such as cancer, are increasingly accepted as relevant in the conservation of natural 
populations (McAloose and Newton, 2009; Metzger and Goff, 2016). Even though cancer is 
widespread across metazoan taxa and has been linked to dramatic declines in species 
abundance (Martineau et al., 2002; Lachish et al., 2007), it has been neglected for a long time 
in conservation sciences because it has been thought as an individual condition until recent 
discoveries of transmissible cancers in nature (Metzger et al., 2015; Ruth J. Pye et al., 2015; 
Metzger and Goff, 2016; Madsen et al., 2017).    
 The Tasmanian devil facial tumour disease (DFTD) is a transmissible cancer 
that has dramatically reduced the abundance of Tasmanian devils (Lazenby et al., 2018). This 
cancer increases the mortality of reproductively active individuals as a consequence of 
metastasis to vital organs, interference with feeding behaviour or secondary infections (Loh 
et al., 2006). At the host level, cancer cells can be thought of as parasites, since their survival 
and fitness depend on their capacity to extract and assimilate resources from the host (Ujvari 
et al., 2016). The parasite replication (i.e. tumour cell proliferation) creates a permanent 
demand for resources, which are taken up from the host’s budget (den Broeder et al, 2001; 
DeBerardinis et al, 2008; Vander Heiden et al, 2009; Luo et al, 2014; Hicks et al, 2018). As 
cancer cells develop mechanisms for immune evasion (Siddle et al., 2007, 2013; Pardoll, 
2015), they are often not recognised by the host immune system, and therefore are 
metabolically treated as a host tissue that is undergoing growth. As host energy inputs are 
limited, it follows then that individuals with greater energy resources allocated to growth 
would have less energy available for other functions such as reproduction, performance or 
38 
even maintenance costs. In this scenario, hosts may have at least two strategies in order to 
maintain a positive energy balance: (i) re-allocate energy among competing 
functions, and/or (ii) to adjust metabolic ceilings (limits) to increase energy inputs (Piersma 
and van Gils, 2011). The energetic dimension of diseases in wildlife is thus a key aspect of 
the pathogenic cascade of physiological effects at the individual level (Martin et al., 2018).  
Here we study the field metabolic demand of Tasmanian devils infected with DFTD 
(Loh et al, 2006; R. J. Pye et al, 2015). We predict that infected individuals should present 
with higher Field Metabolic Rates (FMR) than healthy individuals as a consequence of the 
energetic costs of the growing tumour.  
3.2. Methods 
3.2.1. Field metabolic rate 
We measured FMR by the Doubly Labelled Water method (DLW, Nagy et al. 1983). 
Eighteen wild devils (females = 9, males = 9) were trapped during autumn 2016 in an 
infected population in north-west Tasmania (379698 E / 5439909 S), 8 of which had DFTD 
(females = 5, males = 3). Although the 18 devils were injected with DLW following capture, 
only 7 were recaptured during the study period of ten consecutive days.  
At the first capture, each devil was injected subcutaneously with a solution of 
DLW, after which it was left in the trap for at least 4 hours to allow for isotope equilibration. 
Blood samples were collected before injection, 4 to 6 hours after injection and a final sample 
when the animal was recaptured within a 10-day window. We used the two-sample approach 
to estimate the isotope turnover, evaluating its background, initial (equilibration), and final 
levels in blood. Whole blood was centrifuged, and the serum extracted and frozen in vacuum-
sealed tubes for posterior distillation. All individuals were released at the place of capture 
after injection of DLW and after obtaining the blood samples.  
3.2.2. Isotope sample analysis 
Serum samples were vacuum distilled according to Nagy (1983). The isotopic 
composition for d2H and d18O in the distilled samples was determined on a MultiFlow 
headspace analyser coupled to an Isoprime 100 continuous flow isotopic ratio mass 
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spectrometer. To do so, the total of the sample was transferred from the capillary into a 5 mL 
vial, containing a platinum coated resin as catalysator in the headspace above the sample. The 
sample was then equilibrated with 10% H2 in helium at 30 °C for 2h. The equilibrated sample 
gas was cleaned on a GC column at 80 °C and then loaded into the mass spectrometer. The 
applied H3+ correction factor was 3.76. After this, the same sample was equilibrated with 5% 
CO2 in He at 30 °C for 6 hours, the CO2 separated on a GC column at 100 °C and then 
introduced into the mass spectrometer. 
Stable isotope abundances are reported in delta (δ) values as the deviations from 
conventional standards in parts per mil (‰) from the following equation: 
δ X (‰) = [(Rsample/Rstandard -1) × 1000] 
 where X = 2H or 18O and R = the ratio 1H/2H or 16O/18O. Both values are reported 
respective of the Standard mean Ocean Water (SMOW) scale. 
Each batch of 60 samples included at least 15 standards, 3 at natural abundance and 
12 at 4 distinct levels of enrichment. Laboratory standards at natural abundance levels were 
calibrated against SMOW and SLAP and the enriched standards against IAEA-607. Precision 
was 3.0 0/00 for hydrogen and 0.15 
0/00 for oxygen isotopic values, respectively. 
3.2.3. Energy Expenditure and Water Turnover calculations 
CO2 production was estimated by using the single pool model described by Speakman 
(1997, equation 7.17). Initial isotope dilution spaces were calculated by the plateau method 
and used in millilitres assuming a value of 18.020 as body water molecular weight. Final 
dilution spaces were calculated by the percentage method. The average between initial and 
final dilution spaces was used in the final calculations of FMR. The production of CO2 was 
converted into energy expenditure by assuming a Respiratory Quotient (RQ) of 0.8 using the 
Weir equation (1949). Predicted field metabolic rates for mammals of equal body mass were 
calculated by using equation 3 from Nagy (1999). 
3.2.4. Statistical analysis 
Multi-model inference with an information-theoretic approach (Burnham & Anderson 
2003) was employed to contrast the adequacy of four working hypotheses (the candidate 
models) about FMR and water turnover. Given our low recapture rate, which resulted in a 
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small sample size (N = 7), we kept to a minimum the number of candidate models (4) to 
minimize the likelihood of spurious results (Burnham & Anderson 2003). Therefore, we 
evaluated as explanatory variables only the single effects of body weight, body condition, 
disease status and total tumour volume. Sex was not included in the model formulations due 
to its correlation with disease status (all healthy individuals were males, while diseased 
individuals were females). All analyses were carried out in R version 3.4.1.   
3.3. Results 
A total of 7 individual devils (4 males and 3 females) including 5 adults and 2 
juveniles were recaptured and then their metabolic rates measured during the field-
experiment (Table 3-1). Male individuals presented an average body mass of 6,733 ± 763 
grams, while females presented an average mass of 5,850 ± 239 grams. DFTD status of the 
sampled individuals presented a sex bias with all the infected individuals being females. 
Cancer burden measured by total tumour volume in females ranged between 0, in the healthy 
individual, and 299,758 mm3. The reproductive status of females also varied between females 
lactating with two and three active teats, and no lactation (no reproductively active) in the 
case of the juvenile individual and the female presenting the largest tumour burden.  
Overall, FMR was higher in the female individuals with DFTD, relative to the males 
without DFTD (Table 3-1, Figure 3-1). The model selection indicated that from the 4 
candidate models tested, there was no single best-fit (Table 2). The model containing total 
tumour volume was the most supported (Akaike weight of 0.44) and an R2 = 0.25. The 
second and third ranked models included disease status and body condition as predictors, 
respectively, and showed Akaike weights of 0.29 and 0.18, respectively. The least supported 
model included body weight as predictor and accounted for only 8% of the AIC weights and 
a R2 ≈ 0. 
Consistent with FMR, water turnover was higher in diseased than healthy individuals 
(Table 3-1). The model selection indicated that two models presented with an equivalent 
goodness-of-fit (Table 3-2). The model for disease status had the most support (Akaike 
weight of 0.68, and R2 = 0.62), followed by the model containing total tumour volume 
(Akaike weight of 0.29, and R2 = 0.51). Models including body weight and body condition as 
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predictors presented limited support with delta AIC values of 7.03 and 8.08 and Akaike 
weights of 0.02 and 0.01, respectively and R2 ≈ 0.  
Table 3-1 Individual information, water turnover, and metabolic demand of wild Tasmanian 
devils. 
Table 03-2 Model structure and selection summary for field metabolic rate and water 
turnover in wild Tasmanian devils. 











ml kg-1 d-1 










(FM  d-1) 
kJ kg-1 d-1 
1 M  J 0  NA 6100 62 91.32 119.85   275.30   303.75   380.87 320.09 
2 M  A 0  NA 6500 64 55.86 62.05   341.98   380.78   532.25 280.38 
3 M  A 0  NA 8200 68 73.94 73.98   356.08   374.46   631.17 337.39 
4 F  J 0  0 5500 64 86.13 80.18   401.43   414.47   468.58 301.12 
5 F  A  12,06  3 5500 78 253.96 265.33   389.62   446.98   505.34 295.64 
6 F  A 110,58  2 5900 72 130.53 138.83   476.52   543.59   659.25 264.81 
7 F  A 299,75  0 6100 73 164.72 164.66 1118.15 1175.87  1474.41 283.35 
Model terms AIC ΔAIC AICw R2 
Field Metabolic Rate 
FMR = 505.08 + (51.45 ± 29.57)   x log10(Total Tumour Volume) 109.76 0 0.44 0.25 
FMR = 418.30 + (315.70 ± 217)  x (Disease Status yes/no) 110.60 0.84 0.29 0.15 
FMR = 1800 – (1312 ± 1177)   x (Body Condition) 111.52 1.76 0.18 0.03 
FMR = 423 + (223.8 ± 0.32)  x (Body weight kg) 113.07 3.31 0.08 ≈ 0 
Water Turnover 
WT = 76.81 + (106.26 ± 32.16)     x (Disease Status yes/no) 83.87 0 0.68 0.62 
WT = 108.81 + (14.35 ± 5.26)  x log10(Total Tumour Volume) 85.61 1.74 0.29 0.51 
WT = 476.09 – (0.06 ± 0.06)  x (Body Weight kg) 90.91 7.03 0.02 ≈ 0 
WT = 161.44 – (41.16 ± 290.83)   x (Body Condition) 91.95 8.08 0.01 ≈ 0 
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Figure 3-1 Metabolic demand in healthy and diseased Tasmanian devils. Large squares 
represent the mean for each group. 
Figure 3-2 Tasmanian devil infected with DFTD active during day time. 
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3.4. Discussion 
Energy balance is a major driver of the ecology and evolution of organisms and it is a 
critical component of the pathophysiology of diseases at the individual level. We present the 
first evidence of enhanced field metabolic rates and water turnover in wild Tasmanian devils 
infected by a transmissible cancer, Devil Facial Tumour Disease. Infection status and cancer 
progression, measured either as diseased or healthy individuals or total tumour volume, 
showed consistent relationship with enhanced field metabolic demand and water turnover of 
the harbouring host. The metabolic demand in infected individuals may directly compromise 
fitness components of the host such as survival and reproduction. Further studies with larger 
sample sizes of infected individuals should examine whether some hosts may be able to cope 
with the increased metabolic expenditure at tumour burdens below a threshold after which 
energy reallocation comes at a cost to other organic functions. Our results enhance 
understanding of cancer progression at the individual level and reveal how metabolic demand 
shapes the pathophysiology of DFTD.  
Our results suggest that DFTD infection and progression may affect the field 
metabolic rate and water turnover of infected Tasmanian devils. Although, it is important to 
highlight the limitations of our study derived from the small sample size and the sex bias in 
the infection status (all infected individuals were females), our data supports an enhanced 
metabolic demand derived from cancer progression. Overall, all infected individuals 
presented higher field metabolic rates and water turnover than healthy ones. In the case of 
water turnover, infected individuals presented values of at least 60% higher than the mean of 
healthy individuals (mean water in = 76.81 ml kg-1) regardless litter size. The highest value of 
water turnover was recorded in an infected female with a small tumour volume, in which case 
it may reflect the demand from the litter. In the case of the infected individual without pouch 
young the water turnover presented values higher than in healthy individuals but intermediate 
in relation to the other two infected females. These findings might support that tumour 
burden may drive water turnover to levels similar to a medium size litter. In the case of field 
metabolic rate (FMR), infected individuals presented higher values than healthy individuals. 
The maximum FMR recorded was in an infected female with the maximum recorded tumour 
volume (~300 ml) which did not present dependent pups, however it presented an FMR 
equivalent to more than twice the one recorded for the other infected individuals. This finding 
suggest that large tumours in late stages of progression may represent a metabolic demand 
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which may surplus the one derived from reproduction in female Tasmanian devils. Thus, one 
potential strategy of females to cope with the cancer when infected during pregnancy or 
lactation may be by adjusting litter size (Ruiz-Aravena et al, 2018). 
Field Metabolic Rates operates on both host and pathogen at the time of infection 
imposing simultaneous restrictions on their performance and overall biology. We predict that 
metabolic rate may act as a pacemaker of the devil-cancer ecology. Metabolic rates are 
expected to act on the extended phenotype of the interaction between host-pathogen, 
favouring efficient strategies of joint energy exploitation of both, devil and tumour. From the 
devil perspective, though only measurable for one individual, the fitness costs of this chronic 
disease – host fitness association was evident in one infected female in this study, which was 
of reproductive age but with no pouch young and presented the highest metabolic demand 
and largest tumour volume. From the DFTD perspective, the enhanced FMR induced by the 
growing tumour may compromise the cancer fitness by two means: increasing cell death or 
decreasing transmission rate. In the first case, as DFTD is a chronic condition in which host 
energy demand increases over time as a consequence of the uncontrolled replication of 
tumour tissues, the enhanced metabolic demand increases the chances of tumour cells dying 
of necrosis due to ‘metabolic catastrophe’ (demand is higher than the energy available) (Jin et 
al., 2007). Alternatively, since DFTD fitness is linked to its capacity to be transmitted to a 
new hosts by direct contact, the higher FMR of infected hosts may alter the transmission 
likelihood by inducing behavioural changes in infected individuals (Funk et al., 2010; 
Ezenwa et al., 2016). For instance, infected hosts may change their foraging patterns to 
compensate for the high demand of nutrients (i.e. extending foraging hours or decreasing 
searching periods) (Bohn et al., 2016; Martin et al., 2018), potentially affecting the patterns 
of social interactions. This is supported by anecdotal records of sightings of individuals in 
advance stages of infections during daytime. Other changes in behaviour may derived from 
the progressive weakness experienced by infected individuals as cancer burden increases 
(Ruiz-Aravena et al., 2018) which may reduce their ability to compete for food or 
reproduction and therefore affect their potential contacts with other individuals in the 
population (Hamede et al., 2008; Hamilton et al., 2019). Further field studies with larger 
sample sizes will prove valuable to assess how strongly the metabolic demand in infected 
devils translates into epidemiological patterns of DFTD in the wild by affecting transmission, 
tolerance and resistance to the cancer.  
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This chapter has been published in Proceedings of the Royal Society B as: 
Ruiz-Aravena M, Jones ME, Carver S, Estay S, Espejo C, Storfer A, Hamede RK (2018) Sex 
bias in ability to cope with cancer : Tasmanian devils and facial tumour disease. Proceedings 
of the Royal Society B 285: 20182239. 
4.1. Introduction 
Host and pathogen populations are entangled in ongoing conflicts of interest which 
result in complex eco-evolutionary dynamics. Pathogens exploit host resources to replicate 
and transmit, a process that imposes fitness costs on the host (Finnerty et al., 2017; Simpson 
et al., 2016).  Hosts express two distinct defence strategies to cope with infection and 
decrease the effects of pathogen burden: resistance and tolerance (Råberg et al., 2009; Simms 
and Triplett, 1994). Resistance is a mechanism by which hosts directly attack the pathogen, 
reducing pathogen burden and therefore negatively affecting pathogen fitness. Tolerance, on 
the other hand, is a mechanism by which the host can buffer the negative impact of infection 
on its health without reducing the pathogen fitness (Råberg et al., 2009; Schneider and Ayres, 
2008; Svensson and Råberg, 2010). There are epidemiological and ecological costs and 
benefits for a host investing in either of these energetically expensive defence mechanisms 
(Knutie et al., 2017; Restif and Koella, 2004), and hosts tend to display the strategy, or 
combination of both, that provides the best cost/benefit balance (Best et al., 2014; Råberg et 
al., 2007; Read et.al., 2008; Roy and Kirchner, 2000). Tolerance, which translates to host 
ability to cope with infections is proposed to be more beneficial to hosts than resistance when 
the risk of becoming infected is high as a result of high disease prevalence (Best et al., 2014; 
Roy and Kirchner, 2000). This strategy may increase the infectious period in hosts, and 
therefore may also benefit the pathogen in the long term by increasing pathogen prevalence, 
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and with it the benefits of hosts carrying genes able to buffer the impacts of infection in the 
population (Roy and Kirchner, 2000). On the other side, resistance would decrease pathogen 
prevalence in the host population, and as a result the benefit for resistant genotypes will 
decrease in the long-term. The reduced prevalence, at a cost for pathogen fitness, would act 
as a selective force in favour of pathogen genotypes expressing strategies to counter balance 
host resistance. Thus, the evolution of resistance will drive the host-pathogen evolution to an 
arms race or red queen dynamic, while tolerance may lead the system towards a stable 
evolutionary dynamic and eventually coexistence (Read et al., 2008).  
The effect of disease progression on host health can be illustrated graphically by 
plotting the reaction norm of host health as predicted by pathogen burden (Råberg et al., 
2009b; Simms, 2000). The slope of the resultant curve indicates the level of host tolerance to 
infection, with a horizontal (zero) slope indicative of a completely tolerant individual and a 
negative slope, a potentially less tolerant one. Hence, the steeper the slope, the greater the 
impacts of pathogen burden on host health. The resultant slopes provide information about 
the overall impact of the disease on a group of hosts, allowing comparisons between groups 
or populations, (e.g. sexes, age classes, genotypes, sites). The intercept of the graph (called 
vigour) may indicate the level of health or fitness of the host population when there is zero 
pathogen burden (Råberg et al., 2009).  
Here, we investigate the effect of a recently emerged infectious disease on body 
condition of wild Tasmanian devils. By using body condition as a proxy for health, we assess 
the shape and magnitude of the reaction norm of host health to the progression of devil facial 
tumour disease (DFTD), a transmissible cancer. DFTD is characterised by solid tumours 
growing on the facial, oral and neck region of Tasmanian devils (Sarcophilus harrisii) (R 
Loh et al., 2006). The infectious agent is live tumour cells transmitted by direct inoculation 
when susceptible and infected individuals bite each other (Pearse and Swift, 2006). In almost 
100% of cases, the host dies within 12 months after the clinical presentation of a solid tumour 
(McCallum et al., 2007). This high mortality has diminished wild Tasmanian devil 
populations locally by more than 90% (McCallum et al., 2007), with a decline in median 
density of 77% across 80% of its distributional range (Lazenby et al., 2018). Disease-induced 
extinction of devils in the wild was raised as a genuine concern, based on the frequency-
dependent transmission mode of  DFTD  (McCallum et al., 2009), however, the species has 
persisted in the long term in infected areas, though in low numbers. Evolution in the 
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interacting host and pathogen populations may be the cause of the persistence of devils in the 
wild. Changes in tumour variants (Murchison et al., 2012; Pearse et al., 2012) and in the 
epidemiology and population impacts associated with tumour lineage replacement (Hamede 
et al., 2015) have been described, as well as spontaneous tumour regressions (Pye et al., 
2016). From the host side, immune responses against cancer, and rapid changes in the 
genome in populations related to disease arrival have been reported (Epstein et al., 2016). 
Epstein et al. (2016) identified seven genes in two regions of the genome that may be under 
selection. In a second study, analysing the data generated by Epstein et al. (2016), the authors 
identified 97 signatures of selection potentially associated with cancer and behaviour related 
phenotypes in devils (Hubert et al., 2018). Finally, a recent study has found associations 
between SNPs and DFTD-related phenotypes (i.e. survival to infection, age of first infection) 
in devils, reporting differences between males and females, with much more phenotypic 
variation being explained by SNPs in females than male devils (Margres et al., 2018). All of 
these genome-focused findings suggest an ongoing evolutionary process between devils and 
DFTD, in which this newly emerged pathogen represents an intense selective force on host 
populations (Hubert et al., 2018). Evaluation of phenotypic changes in tolerance and 
resistance which may shed light on functional interactions between cancer and host is limited. 
In this context, the Tasmanian devil and its transmissible cancer provides a case study system 
to examine how hosts and pathogens interact at both individual and population levels in the 
early stages of their ecological and evolutionary history. 
4.2. Methods 
4.2.1. Study sites and sampling 
Two study sites of 25 km2 were established in northwest Tasmania, Australia, in the 
localities of West Takone (379369 E / 6440624 S) and Wilmot (426417 E / 5414182 S). The 
devil populations at the two sites were each sampled ten times, at three-month intervals, 
between February 2015 and August 2017 (February 2016 was not conducted) to address 
seasonal and physiological changes due to reproduction. Each field session consisted of 10 
continuous trapping days deploying 40 custom-built carnivore traps. On the first capture, 
each individual devil was permanently marked with a subcutaneous microchip, and sex and 
age (using tooth wear, accurate to 3 of 5 years lifespan) were determined. Body mass and 
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head width (zygomatic width) were recorded as morphometric proxies. For individuals 
presenting with clinical signs of infection with DFTD, a photo-identification of individual 
tumours was captured, and the maximum length, width and depth of tumours measured, 
volume being calculated later using the ellipsoid volume formula. Infected devils often 
presented with more than one tumour in various locations on the body at the same time, 
therefore total tumour volume was calculated by summing the volumes of all tumours present 
in a host at the time of observation. Total tumour mass was calculated assuming a density of 
1.1grams per ml of volume as described for soft tissues of similar composition than DFTD 
cells (Woodard and White, 1986). 
4.2.2. Body condition 
We applied an index based on the relationship between body weight and body size, 
that is widely used for measuring and comparing body condition in individual mammals 
(Stevenson and Woods, 2006). The body condition index was calculated by dividing the body 
weight (body weight minus tumour weight) for each individual by the body weight expected 
from the linear regression of body weight with head width (a precise measure of animal size 
because it is measured across bone - the jugal arches - with minimal overlying tissue), both 
log-transformed, for the population. The resulting index represented a proportion between 
actual and expected weight. Study site was not included as a factor in the regression models 
constructed to build a generic allometric relationship for devils. The regression equation was 
built using observations only from clinically healthy individuals (no macroscopically detected 
tumours). This index provided a biologically meaningful indicator of how much above or 
below the expected body mass an individual was according to its body size. Independent 
linear regressions were fitted for males and females to take account of sex differences in the 
relationship between body mass and body size. The subsequent analyses used the body 
condition index according to the respective equation for males and females.  
4.2.3. Effect of DFTD progression on body condition 
The effect of disease progression on body condition was assessed by using 
Generalized Additive Mixed Models to account for potential non-linear effects of cancer 
progression on body condition index. We used two proxies of pathogen burden or disease 
progression as predictor variables, in this case: i) total tumour volume (Tvol), which was the 
arithmetic sum of the individual volume of all observable tumours present on a host at the 
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time of measurement; and ii) an estimate of the ratio between total tumour weight and body 
mass (T/B). The latter index proportionated an indicator of pathogen burden in relation to 
host body mass. Preliminary analyses were conducted to assess potential differences in 
maximum tumour burden recorded in males and females (details in Supplementary Material). 
Season and Julian day were also included as non-linear variables in model formulations to 
consider for natural changes in body condition that devils experience through the year 
because of life history events such as reproductive effort. Thus, season and Julian day were 
transformed to circular variables using its cosine transformation in model formulations. We 
included individual as a random effect in the model formulations to account for non-
independent observations because of the repeated measures from the same individual devils 
at various times. Field trips were conducted in summer - February, autumn - May, winter - 
August and spring - November of each year. We formulated a total of eight models, 
accounting for all single and pairwise combinations of the four predictor variables, avoiding 
building models that included correlated variables: tumour volume vs. tumour body weight 
ratio, and season vs. Julian day. We applied a multi-model selection approach based on 
Akaike Information Criteria (AIC) to rank the models (Burnham and Anderson, 2002). We 
calculated relative importance of the predictor variables by adding the model weights for all 
models including each variable. This analysis was run using only adult individuals (>18 
months old) with clinical infection. Finally, we included the statistical significance for the 
smooth terms included in the best fit models to assess for sex differences influencing the 
effects of the other explanatory variables. All statistical analyses were conducted in R 
software version 3.4.1.    
4.3. Results 
A total of 625 capture events and observations were recorded during the study period. 
The total data set included 298 individual Tasmanian devils (158 females and 140 males). A 
total of 462 observations of healthy individuals were used to fit the allometric curve to 
calculate the body condition index with 237 and 225 observations for female and male devils, 
respectively. A total of 96 observations of infected females and 67 of infected males were 
recorded, which comprised the dataset analysed to test the effect of disease progression on 
body condition. 
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4.3.1. Effects of variables on body condition 
The model with most support (97.4% of AIC weights) included T/B and its interaction 
with host sex and explained 49.8% of the null deviance (Table 4-1). All others seven model 
formulations presented little support, however they evidenced significant statistical effects. 
Tvol alone and the interaction of Tvol with host sex, showed an overall significant effect on 
host body condition (p = 0.039, and 0.023, respectively), and the models explained 24.4 and 
29.3% of the null deviance. Season and Julian day showed also limited explanatory capacity 
in the analyses (AICw ≈ 0). The variable importance calculation showed that T/B is the most 
important variable in explaining the body condition of infected devils (99.95%), followed by 
host sex (97.4%).   
4.3.2. Sex-specific differences in tolerance to DFTD 
The shape and magnitude of change in body condition differed between sexes (Figure 
1). Disease progression presented a significant stronger effect on males than in females (p = 
0.001). This pattern was consistent across the two measures of disease progression Tvol and 
T/B (Figure 4-1a – d). T/B showed an almost linear (negative) effect on body condition of 
males, decreasing body condition by approximately 25% between the early and late stages of 
the disease (Figure 4-1b). In females, T/B presented a similar negative trend with an overall 
decrease in body condition of approximately <5% at T/B of more than double the 
experienced by males (Figure 4-1a). Despite the low support presented by the models 
including Tvol, a significant effect of Tvol and its interaction with sex was detected (p = 
0.039 and 0.023, respectively). both sexes presented with similar maximum values of total 
tumour volume. While the curve for females shows that they may be able to almost maintain 
their body condition with disease progression (Figure 4-1c), in males the effect follows a 
non-linear shape with a slight capacity to maintain their body condition in initial stages of 
infection (Tvol < 3) followed by a decline of approximately 15% between middle and large 




Intercept Model terms p-value+ AIC ΔAIC AICw (%) D2 
 0.003 s1(T/B, df = 0.744) 0.047* -233.585 0 97.40 49.8 
s2(T/B:Female, df ≈ 0)  0.494 
s3(T/B:Male,  df = 0.921) 0.001** 
 0.004 s1(T/B, df = 2.267) - -226.300 7.285 2.55 23.3 
 0.003 s1 (Season, df = 1.316) - -217.742 15.843 0.03 38.7 
 0.004 s1 (Tvol, df = 1.848) - -213.531 20.054 ≈ 0 24.4 
 0.003 s1 (Day, df ≈ 0)  
- 
-212.473 21.112 ≈ 0 32.2 
s2 (Day:Female, df ≈ 0) 
s3 (Day:Male, df = 1.741) 
 0.006 s1 (Tvol, df = 1.145)  
- 
-211.534 22.051 ≈ 0 29.3 
s2 (Tvol:Female,  df ≈ 0)  
s3 (Tvol:Male,  df = 0.796) 
 0.003 s1 (Day, df ≈ 0) - -209.092 24.493 ≈ 0 28.8 
0.004 
s1 (Season, df = 1.323) - -205.421 28.164 ≈ 0 30.9 
s2 (Season:Female,  df ≈ 0) 










Table 4-1 Results from the Mixed effects Generalized Additive Models analysing the effects of 
seasonality and cancer progression on body condition of Tasmanian devils infected with DFTD. 
T/B = Tumour weight – host body weight ratio; Tvol = Total tumour volume; Day = 
Julian day of the year; Season = season of the year. Significance levels of the smooth terms for 











Figure 4-1 Effect of cancer burden on body condition of female and male Tasmanian devils. 
(a,b) Reaction norms of body condition by tumour-body weight ratio for (a) females and (b) 




We present an evaluation of the effects of disease progression on host body condition 
in wild populations using a field-based approach. Our study is the first evaluation of tolerance 
to infection at the population level in a recently emerged transmissible cancer in wild 
Tasmanian devils. Disease state, as measured by cancer burden (tumour - body weight ratio, 
and total tumour volume), has an overall negative effect on body condition of hosts infected 
with DFTD, with a much greater magnitude of the effect on male than on female devils, 
suggesting a sex bias in tolerance to this transmissible cancer. The sex differences in the 
shape of the reaction norm of body condition as disease progresses suggest that proximate 
strategies to cope with infection and their consequent evolution should differ between male 
and female hosts. This could result in differential fitness of infected males and females, with 
sex-linked survival and fecundity rates as energy reserves deplete.  
Our results reveal sex-related differences in the effects of cancer progression on 
Tasmanian devils. Tumour to body weight ratio (T/B) and total tumour volume (Tvol) have 
an overall negative effect on the body condition of infected individuals, with a much stronger 
negative effect in males than females (Figure 4-1). These sex differences are demonstrated by 
a significant interaction between sex and disease progression in the model formulations. 
Tumour to body weight ratio presents a significant negative linear effect on body condition of 
males, which may suffer declines of approximately 25% of body condition when cancer 
burden reaches around 3% of the body weight. This is of a similar magnitude to the 
reproductive cost in loss of body condition experienced by non-infected males during the 
mating season (Jones et al., 2008). In contrast, the negative effect of T/B on females is much 
less, with body condition declining by approximately <5% when tumour weight reaches 6% 
of host body mass. Models including total tumour volume have less support than for T/B. 
Tumour volume in males shows a non-linear effect on body condition with a marginal 
increase at initial stages of the infection, a detrimental effect at around tumour volume of 3 
(log10 scale of mm
3) and an overall loss of approximately 15% in body condition.  In contrast, 
body condition of females appears to be less influenced by tumour volume than by T/B, 
although condition trends down at larger tumour volumes.  
There is an apparent overall threshold in tumour volume (of 3; log10 scale of mm
3), 
after which body condition declines in males, and slightly in females. This finding is 
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consistent with theoretical findings that infected individuals potentially have higher survival 
than non-infected ones at low tumour volumes, but lower survival than non-infected 
individuals when tumour burden is higher than 100 ml (Wells et al., 2017). This pattern may 
suggest a threshold for cancer burden, at which infected individuals may be able to 
completely tolerate the infection. This level of cancer burden may also represent a 
physiological and metabolic landmark indicating the moment at which the disease becomes a 
significant compromise to the fitness of the host. (Louie et al., 2016).  
Body condition in wild populations is expected to vary according to the ecological 
context in which organisms inhabit, and to follow seasonal patterns of availability of 
resources and reproductive investment (Simard et al., 2014). Tasmanian devils are seasonal 
breeders, with the mating season taking place in late summer and early autumn (Keeley et al., 
2012b, 2017). This pattern allows juveniles to be weaned during mid and late spring. The 
costs of reproduction are expected to differ between sexes in magnitude and timing. Energetic 
demands are expected to peak during the mating season in males (Hesterman and Jones, 
2009), and during the second half of lactation in females, starting in winter when they are 
carrying large pouch young up until early-summer when the denned young are weaned 
(Hesterman et al., 2008a, 2008b). The limited support for models that include seasonal 
variables (season and Julian day) suggests that cancer progression may over-rule the effect of 
seasonality on body condition of infected individuals. As cancer progresses, its growth and/or 
secondary complications (Loh et al., 2006; Peck et al., 2016) may increase the energetic 
demand of infected individuals with a stronger effect on the resulting body condition than 
that driven by seasonal patterns of reproduction and food availability. The lack of a seasonal 
effect in females may reflect plasticity in their ability to manipulate reproductive costs by 
reducing provisioning and number of young in a litter according to environmental conditions, 
or a response to increased resource availability as populations decline well below carrying 
capacity due to DFTD-induced mortality. The latter effect has been proposed as the proximal 
cause of the increased proportion of precocial breeders in diseased populations (Jones et al., 
2008).  
The differences in tolerance to cancer progression between males and females may 
select for changes in life history strategies in the host and could also alter the selective 
environment for the tumours. As the impact of disease progression on host health differs 
between the sexes, the environmental and ecological context for the cancer will also differ 
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based on whether the tumour is carried by a male or a female devil. Body condition is directly 
linked to survival and reproductive success in natural populations (Budischak et al., 2017; 
Wauters and Dhondt, 1995) and the ability to tolerate infection, and maintain body condition 
as pathogen burden increases, is therefore a trait potentially under selection. There are two 
main influences from DFTD on life history plasticity in both sexes of devils. The first is high 
mortality following the first mating season (Lachish et al., 2009), when much of transmission 
is thought to occur through biting behaviour (Hamede et al., 2008, 2013), placing selection 
pressure on terminal investment, expressed as early or precocial breeding in the first year of 
independent life (Jones et al., 2008). The second is the increased growth rates in juveniles, 
enabled by improved nutrition following severe population decline, that can facilitate early 
sexual maturity and precocial breeding (Lachish et al., 2009). Reproduction and mating 
systems place different energetic demands and selection pressures on males and females and 
so they may respond differently, in the flexibility they have in energy allocation and in life 
history. Increased precocial breeding in female devils (Jones et al., 2008; Lachish et al., 
2009) extends the reproductive season for males, which can mate multiple times since their 
reproductive investment is not influenced by seasonality (Keeley et al., 2012a). This may 
allow infected males, which already have compromised energy resources from DFTD that are 
equivalent to mating season effort, to spread their reproductive effort over a longer time 
period instead of the intense, short mating season that occurs in healthy populations 
(Hesterman and Jones, 2009). Females, on the other hand, are constrained to one litter per 
year but flexibility in reproductive effort may be available through manipulating sex ratio, 
litter size and maternal investment in that litter (Lachish et al., 2009).  
Phenotypic variation among individuals in natural populations, that has a genetic 
basis, is the basis upon which natural selection acts. The genetic basis of and phenotypic 
variability in tolerance and resistance to infection has been documented in wild populations 
and demonstrated to be under selective force (Anaya-Rojas et al., 2016; Hayward et al., 
2014b, 2014a). Tolerance and resistance differ in their associated costs. Resistance is 
potentially costlier to the host than tolerance, perhaps as a consequence of the level of the 
specificity of the underlying mechanisms (e.g. production of antibodies that confer 
resistance) (Moret and Schmid-Hempel, 2000). In the devil—DFTD system, fitness costs 
associated with a host immune response (resistance) are indicated by tumour strategies which 
allow them to evade immune recognition, such as down-regulation of MHC expression 
(Siddle et al., 2013). Evidence of resistance against DFTD is sparse. Despite devils having a 
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fully competent immune system and the ability to mount immune responses to DFTD when 
induced (Pye et al., 2018; Tovar et al., 2017), the incidence of spontaneous tumour regression 
in wild populations is currently low. However, some wild devils whose tumours have 
regressed spontaneously have shown immune responses to DFTD (Pye et al., 2016) and 
genome-wide association analysis of these devils reveals two genomic regions potentially 
associated with the ability to spontaneously recover (Wright et al., 2017). With tolerance, the 
costs associated with proximal mechanisms may be lower than for resistance. Generic 
strategies, such as energy reallocation do not require specific biochemical “machinery” to be 
put in action. This could potentially result in the emergence of tolerance earlier than 
resistance in the evolutionary time of new host-pathogen interactions, as in  the devil-DFTD 
system. (Lachish et al., 2009; Trivers and Willard, 1973). It is possible that the changes in 
tumour lineages (Hamede et al., 2015), epidemiology (Hamede et al., 2011), and sex 
differences in individual survival (Margres et al., 2018) in infected populations are a 
consequence of distinct levels of effects of DFTD infection, that are related to sex and body 
mass of the host, where males are larger than females. This may result in tumour-male and 
tumour-female systems having a different influence on infective times, behaviour and 
therefore transmission dynamics.  
Cancer has been considered an individual condition with very limited potential to act 
as a force in natural selection, and therefore in evolution. However, an increasing number of 
studies have shown that oncogenic phenomena play an important role in the ecology and 
evolution of their hosts and ecosystems (Thomas et al., 2017; Vittecoq et al., 2013). 
Transmissible cancers, of which only eight naturally occurring cases are known to science, 
behave as infectious agents, but the pathology experienced by hosts are the hallmarks of 
cancer such as uncontrolled cellular replication within tumours, tissue invasion, immune 
evasion and metastasis (Hanahan and Weinberg, 2011, 2000; Ujvari et al., 2016). In this 
context, studying how different host genotypes respond to infection by and progression of 
clonal tumours will help to understand cancer biology in an evolutionary context, which may 
expand our understanding of the internal battle between cancerous and healthy host tissues 
(Frampton et al., 2018; Murgia et al., 2006; Siddle and Kaufman, 2013; Tovar et al., 2017; 
Ujvari et al., 2016; Woods et al., 2007). Cancer risk in humans has been reported to vary with 
factors such as sex (Rakoff-Nahoum and Medzhitov, 2007), occupation (Bayer et al., 2016; 
Hadkhale et al., 2016) and concomitant infections (Restif and Koella, 2004). Studies of 
cancer progression in natural conditions without treatment, which would allow researchers to 
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explore differences in tolerance among patients, are non-existent for ethical reasons. The 
applicability of the concept of tolerance, originally developed by plant ecologists and recently 
incorporated in animal studies, to cancer contexts may provide the framework to understand 
oncogenesis as an important force in ecological and evolutionary processes. Studying cancer 
in evolutionary framework and treating cancer as a chronic condition in which tumours act as 
parasites, may expand thinking around treatment possibilities to target tolerance levels in 
hosts instead of resistance, which is the current approach (Restif and Koella, 2004).  
The devil-DFTD transmissible cancer system is showing signs of evolving at a 
surprisingly rapid rate. By studying the different dimensions of this process, from ecology 
and epidemiology to genomic interactions between host and pathogen, we can expand our 
understanding of cancer biology beyond the specifics of the devil-DFTD system. Evolution is 
a dynamic process and needs to be better studied and factored into management actions; 
whether they be conservation of Tasmanian devils in the wild or cancer treatment in humans 
and domestic animals. Further research to elucidate how much of the individual and sex-
related variability in tolerance is explained by genetic or environmental influences, will 
reveal how natural selection may act in this relatively new host-pathogen system.  
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Chapter 5
Immune response relates to infection and
progression of cancer in Tasmanian devils
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 IMMUNE RESPONSE RELATES TO 
INFECTION AND PROGRESSION OF CANCER IN 
TASMANIAN DEVILS 
5.1. Introduction. 
Transmissible cancers, with their ability to spread among individual hosts, are rapidly 
changing the concept of oncogenic processes being an individual condition with limited 
consequences for evolution of responses in host populations (Ostrander et al., 2016). Because 
transmissible cancers act as infectious pathogenic agents (Metzger and Goff, 2016) and can 
have devastating impacts on host populations (Barber, 2004; Lachish et al., 2007), they have 
the potential to act as strong selective forces on host populations (Epstein et al., 2016) to 
develop “cancer-aware” strategies to optimize their fitness. Therefore, natural selection is 
expected to act in favour of host and pathogen (tumour) variants affecting the dynamics of 
interaction in the long-term (Brunner et al., 2017; Budischak et al., 2017;  Hamede et al., 
2015; Lambrechts et al., 2006), which potentially may lead the systems toward coexistence. 
The oldest cell line on earth is precisely a transmissible cancer, the canine transmissible 
venereal tumour (cTVT) (Murchison et al., 2014; Rebbeck et al., 2009). cTVT affects 
domestic dogs and has developed strategies to survive in its host with very limited 
pathogenicity (Rebbeck et al., 2009). This has favoured transmission and therefore 
persistence of the disease in the dog populations for as long as 10,000 years, with neither 
tumours or hosts experiencing strong selection pressure (Murgia et al., 2006). Hosts of 
transmissible cancers as any other infection may benefit from displaying strategies to control 
the impact of infection on their fitness such as resistance by mounting an immune response 
against the tumour tissue and clear it from their organism (Råberg et al., 2009). Here, we 
assess resistance of Tasmanian devils to the devil facial tumour disease (DFTD), the most 
recently emerged transmissible cancer, by evaluating the relationship between immune 
responses against tumours and its effect on infection status and disease progression.    
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Devil Facial Tumour Disease (DFTD) is the most recently emerged transmissible 
cancer in nature, and affects the Tasmanian devil, the largest extant carnivorous marsupial. 
DFTD has caused a dramatic decline of Tasmanian devil populations in the last 25 years 
leading to their listing as Endangered (IUCN, EPBC Act, state legislation). Since DFTD 
emerged in a female Tasmanian devil in the north-east of Tasmania in the early 1990s, it has 
spread across almost 90% of the devil’s island distributional range in Tasmania, causing 
population declines averaging 80% (Lazenby et al., 2018), but locally up to 95%. Biting 
behaviour during social interactions is thought to be the main route of transference and 
inoculation of tumour cells from infected to naïve hosts (Hamede et al., 2008, 2013). 
Transmission and establishment of DFTD are facilitated by the incapacity of hosts to reject 
tumour cells by immune response (Siddle et al., 2013). Two main hypotheses were 
formulated to explain this incapacity of devils to recognize tumour cells as foreign and mount 
an immune response: i) Low genetic variability in the MHC-I alleles (Morris et al., 2013; 
Siddle et al., 2007), and ii) immune escape strategies from the tumour tissues (Siddle et al., 
2013; Siddle and Kaufman, 2013). Findings in support of the first hypothesis are 
contradictory since the devil immune system has been demonstrated to be competent in 
rejection of allographs (Kreiss et al. 2011), however developmental changes in IgM/IgG 
ratios (Ujvari et al., 2016) and general immune condition (Cheng et al., 2017) may 
compromise protection against cancer. The second hypothesis is supported by findings of 
down-regulation of MHC-I molecules in tumour cells. Thus, tumour cells have the capacity 
of “hiding” MHC-I from their surface which prevents immune recognition and therefore 
rejection by the host immune system (Caldwell and Siddle, 2017; Siddle et al., 2013). 
Regardless of the down-regulation of MHC-I that may compromise or prevent a 
response against DFTD, some hosts are able to detect the cancer and mount an immune 
response  (Pye et al., 2016). Anti-DFTD responses have been experimentally induced by 
vaccination of individuals with antigens from tumour cells by using irradiated or sonicated 
DFTD cells treated with gamma-interferon to induce MHC expression (Tovar et al., 2017). 
This response has been characterized by an increase in IgG antibodies against DFTD in the 
immunized devils. In addition, complete rejection of tumours and recovery of individuals can 
be induced by immune therapy. But it was not until recently that immune responses against 
DFTD were first detected in natural conditions. Pye et al. (2016) first demonstrated the 
occurrence of antibodies (IgG) against DFTD and cell infiltration of tumours in natural 
conditions, suggesting that humoral and cell-mediated responses occur at certain moments of 
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infection by DFTD and therefore the immune escape from tumours may be imperfect. In 
addition, the authors presented individual cases that may suggest the potential for resistance 
to the disease and that devils may be able to reject and recover from cancer, however the 
authors did not perform formal statistical analyses on how the immune response detected may 
influence disease progression. To shed light on the potential mechanisms mediating tumour 
remission, Margres et al. (2018) conducted a genome-wide analyses in devils hosting tumours 
that showed remissions and hosts with tumours that followed the common progression of 
exponential growth. The results did not show differences between devils with regressions and 
devils with tumours progressing, suggesting that if regression of tumours is host-driven, it 
may be associated to differences in gene expression (Margres et al. 2018). Other studies have 
reported changes in genome regions associated with cancer and immune response after just 4 
– 6 generations since disease outbreak (Epstein et al., 2016; Hubert et al., 2018) and
potentially “cancer-resistant phenotypes” (Margres et al., 2018). These findings support that 
DFTD is a strong selective force on devil populations, however there is still a gap in the 
current characterization of tolerance and resistance that may link the genome-level changes to 
functional phenotypic responses. So far, cancer remission and recovery of hosts in the wild 
seem as isolated cases, representing a small proportion of the infected population. This 
condition may be an artefact of capture efforts and low number of populations sampled at 
regular intervals that may allow researchers to follow tumour progression, however natural 
selection is expected to favour evolution of resistance and tolerance to infection in devil 
populations.  
Here, we investigate the host immune response against DFTD and its relationship 
with disease status and progression in wild Tasmanian devils. We sampled devils and 
tumours from two wild populations in north-west Tasmania between 2015 and 2018 and 
evaluate the presence of antibodies (IgG) against DFTD in host serum, and immune cell 
infiltration in tumour biopsies. We then analyse the data evaluating how antibodies may 
relate to infection status and progression, and how immune cell infiltration within tumour 
tissues relates to tumour growth trajectories. We discuss our findings under the context of 
evolution of resistance to the disease and how what has been evidenced as individual 




5.2. Methods.  
5.2.1. Field data and sample collection. 
Two study sites of 25 km2 were established in northwest Tasmania, Australia, in the 
localities of West Takone (379369 E / 6440624 S) and Wilmot (426417 E / 5414182 S). The 
devil populations at the two sites were sampled at three-month intervals, between February 
2015 and February 2018 (February 2016 was not conducted), to address seasonal and 
physiological changes associated with reproduction. The resulting data set comprised 12 
trapping sessions for the Takone site, and 8 sessions for Wilmot. Each field session consisted 
of 10 continuous days of trapping in which 40 custom-built carnivore traps were deployed. 
Upon first capture, each individual devil was permanently marked with a subcutaneous 
microchip, and sex and age (using tooth wear, accurate to 3 of 5 years lifespan) were 
determined. Body mass and head width (maximum width across the zygomatic arch), as a 
linear measurement of size, were recorded. For individuals presenting with clinical signs of 
infection with DFTD, a photo-identification of individual tumours was captured, and the 
maximum length, width and depth of tumours measured, volume being calculated later using 
the formula for ellipsoid volume. Infected devils often presented with more than one tumour 
in different locations on the body at the same time. In these cases, total tumour volume was 
calculated by summing the volumes of all tumours present in the host at the time of 
observation.  
5.2.2. Classification of tumour progression. 
Tumours were classified as “Progressing” or “Non-progressing” according to the 
models of DFTD growth rates described by Hamede et al. (2017), in which minimum growth 
was considered to 0.01 (r) per day. Thus, tumours with a growth rate between successive 
field measurements of greater than 0.01 were classified as “Progressing”, while tumours with 
growth rates below 0.01 were classified as “Non-Progressing”. By using the lowest growth 
rate of 0.01 described by Hamede et al. (2017) as the threshold for classifying tumours, we 
adopted a conservative approach which minimizes the probability of misclassification. The 
non-progressing tumours included cases of static growth and cases of tumour remission 
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(negative growth rate), the latter of which were differentiated for some analyses on tumour 
progression as “regressing”.  
5.2.3. Laboratory analyses 
5.2.3.1. Tumour cell culture for antibodies detection by flow cytometry 
The DFT1 cell line C5065 was maintained in complete RPMI-10, which was RPMI 
1640 (Gibco) supplemented with 10% vol/vol heat inactivated foetal bovine serum FBS 
(Bovogen Biological), 5mM L-glutamine (Gibco) and 1% vol/vol Antibiotic-Antimycotic 
(Gibco). All cell lines were grown at 35oC in a humidified atmosphere of 5% CO2/95% air. 
C5065 were stimulated with recombinant devil IFNγ (50ng/ml) for 24 hours to upregulate 
surface MHC-I expression. MHC-I expression was confirmed by flow cytometry using 
mouse anti-Tasmanian devil (TD) beta-2 microglobulin (β2m), a component of the MHC-I 
complex. Untreated and IFNγ treated DFT1 cells were used for screening of serum from wild 
devils in flow cytometry. 
5.2.3.2. Anti-DFTD IgG detection and flow cytometry 
All staining and washing was performed in FACS buffer (0.5% BSA, 2.5mM EDTA 
and 0.02% sodium azide in PBS). DFT1 C5065 cells were aliquoted onto a round bottom 96-
well plate (Greiner Bio One) at 2x105 cells/well. Cells were stained in 100μl wild Tasmanian 
devil (TD) serum (diluted 1:50), incubated for 30 minutes on ice and then washed three 
times. Cells were then stained in 100μl of 10μg/ml of mouse anti-TD IgG (clone A4/D1; 
WEHI) for 30 minutes and washed again. Cells were then stained in 50μl of 2μg/ml of Alexa 
Fluor® 647-conjugated goat anti-mouse IgG (H+L) (Invitrogen) for 30 minutes. Cell were 
washed again and resuspended in 200μl FACS buffer containing 200ng/ml 4′,6-Diamidino-2-
phenylindole dihydrochloride (DAPI, Sigma Aldrich). Data acquisition was performed on the 
FACS Canto II flow cytometer (BD Biosciences) and data was analysed with FlowJo 
software (FlowJo LLC). Controls included the above cell lines labelled with anti-TD IgG plus 
the tertiary antibody (no primary control) and serum plus the tertiary antibody (no secondary 
control), the serum of a captive immunised devil (positive control) and the serum from a wild 
devil from the DFTD-free insurance population established in Maria Island, Tasmania, with 
high background staining (internal control). No background fluorescence was observed in the 
no primary and no secondary controls.  
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To normalise raw IgG median fluorescence intensity (MFI) data between different 
days (experiments) that samples were analysed, the following calculations were performed: i) 
The average IgG MFI of the internal control was calculated from the raw internal control IgG 
MFI values of each experiment. ii) The raw IgG MFI values of the internal control from each 
experiment was then divided by the average IgG MFI of the internal control to calculate an 
internal control IgG MFI division factor. iii) the adjusted IgG MFI for each sample was 
calculated by dividing the raw IgG MFI by the internal control IgG MFI division factor. The 
raw values from each experiment day were only divided by the internal control IgG MFI 
division factor that was calculated from the internal control sample run on the same day to 
prevent for influences on the data derived from intrinsic variability of the equipment. 
5.2.3.3. Histology and Immunohistochemistry 
Sixty-two tumour biopsies were selected for microscopical examination to confirm 
DFTD diagnosis and the level of infiltrations of immune cells associated with cellular 
immune response. The selected observations included tumours with signs of regression 
(negative growth rate) and randomly selected tumours classified into two categories: 
“Progressing” and “Non-Progressing”. The biopsies from devils were screened for DFTD by 
periaxin staining by immunohistochemistry (IHC) to confirm that they were DFTD tumours. 
Regressions were confirmed by analysing tissue structure and immune cell infiltration by 
immune histochemistry (IHC) and histology. Standard hematoxylin and eosin (H&E) and 
immunohistochemical staining with rabbit anti-human periaxin (HPA001868; Sigma 
Aldrich), rabbit anti-human CD3 (A0452; Dako), mouse anti-human HLA-DR, alpha-chain 
(clone TAL.1B5; Dako), mouse IgG1 isotype control (clone MOPC-31C, BD Pharmingen) 
and rabbit IgG isotype control were performed on 3 mm sections of tumour biopsies fixed in 
10% neutral buffered formalin and embedded in paraffin. Assessment of stained biopsies was 
performed blind by a human pathologist. Visualisation and image acquisition was performed 
on an Olympus BX-50 light microscope fitted with a Leica DFC320 camera. 
5.2.4. Statistical analyses 
For all analyses, I used a Bayesian Generalized Linear Mixed Models (GLMM) 
approach, with Markov Chain Monte Carlo algorithms (MCMC). The chains were sampled 
by using the Metropolis-Hastings method defined in the MCMCglmm package for R. All 
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analyses were conducted using R Project for Statistical Computing Version 3.5.1. The 
specific model formulations associated with each response are detailed below:  
5.2.4.1. Disease status and humoral response against DFTD. 
The probability of a captured individual devil showing detectable tumours was 
modelled as a binary response in the MCMCglmm formulation. Predictor variables included 
host sex, head width as a continuous proxy of physiological age, and median 
immunofluorescence from the antibodies detection test as a continuous numeric proxy of 
titres of anti-DFTD antibodies. The interactions of sex and age, and sex and median 
immunofluorescence as predictor variables were included in the model. Individual devil and 
experiment identification (see methods of antibody detection) were included as random 
variables to account for multiple samples of the same individuals. The data included in this 
analysis comprised 147 observations collected from 49 individual Tasmanian devils from the 
Takone site. To account for different risks of infection or probability of exposure between the 
two sites due to differences in DFTD prevalence, only one site was selected for this analysis.  
5.2.4.2. Effects of antibodies on tumour progression 
Classification of tumours as “Progressing” and “Non-progressing” was modelled as a 
binary response in a MCMCglmm formulation (Family = categorical). Sex, median 
immunofluorescence from the antibody detection test and their interactions were included as 
predictor variables. Since the dataset included tumours measured on more than one occasion 
in the same host, an interaction term between individual devil and tumour ID, and experiment 
ID as random variables were included in the model. The data set included 86 observations, 
including 63 tumours recorded from 28 individual Tasmanian devils.   
5.2.4.3. Effect of cellular infiltration on tumour progression 
Classification of tumours as “Progressing” and “Non-progressing” was modelled as a 
binary response in a MCMCglmm formulation (Family = categorical). Predictor variables 
included the four variables evaluated in the histopathological examination of tumour 
biopsies: MHC-II intra and peritumour, and CD-3 intra and peritumour. Since the number of 
samples for which values were obtained for each of the four variables varied, I formulated 
four independent models for each predictor variable. The interaction between individual devil 
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and tumour ID (within devil) was included as a random variable. The dataset included a total 
of 61 observations of 46 tumours recorded from 32 individual Tasmanian devils. 
5.3. Results. 
5.3.1. Infection status and humoral response against DFTD. 
The infection status, modelled as the probability of an individual devil to show signs 
of DFTD, was influenced by body size and showed trends supporting sex differences in its 
relationship with IgG (Table 5-1). There was a positive relationship in both sexes between 
body size and the probability of individual devils to show signs of infection by DFTD (Figure 
5-1A). There was no statistical relationship between median fluorescence intensity for IgG
and the risk of infection, but the model did show a positive trend in the interaction between 
sex and MFI and infection status, with male devils presenting a higher probability of showing 
tumours as MFI increased relative to females (Figure 5-1B).  
5.3.2. Tumour progression and immune response. 
The effects of immune responses on the classification of tumours as progressing and 
non-progressing varied among predictors. In the case of humoral response, the model 
formulation including median fluorescence of IgG detection and sex did not show statistical 
relationship with the probability of tumours to be classified in either category (Table 5-2). In 
the case of the histopathological findings, the probability that a tumour progressed was lower 
as the number of antigen-presenter cells (MHC-II positive) present in the peritumour tissue 
increased (Figure 5-2A). The number of MHC-II positive cells in the intra-tumour tissue, or 
CD3 positive cells in the intra and peri-tumour tissue did not show a significant relationship 
with tumour classification (Table 5-2). In addition, no effect of host sex was detected (Table 
5-2).
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Table 0-1 Results from the MCMC Generalized Linear Mixed Model for factors that 
influence the risk of infection by DFTD in Tasmanian devils. 





Intercept -14804.65 -26628.77 -2425.82 589 0.01 * 
Sex Male -8328.56 -29686.31 12306.09 703 0.37 
Log10Head Width (mm) 7230.51 936.12 14608.38 605 0.01 * 
Log10 MFI IgG 18.84 -590.17 599.53 900 0.93 
Sex Male : Log10Head Width (mm) 2382.79 -7522.66 12933.07 718 0.60 
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Figure 5-1 Probability of individual devils to present clinical signs of infection by DFTD as a 
function of body size measured by head width (A) and detection of anti-DFTD IgG (B) for 
males (light blue) and females (orange lines). The curves depict the mean probability and 




Table 5-2 Results from the MCMC Generalized Linear Mixed Model for the effect of 






Model Model term Post. 
Mean 






Intercept -3368.5 -9384.5 2059.5 1071 0.185 
Sex Male -5673.7 -16691.8 3503.2 1131 0.202 
MFI IgG 947.5 -704.0 2817.3 1179 0.231 




Intercept -195.82 -437.03 -2.59 655 0.021* 
Sex Male -60.24 -424.98 333.68 1107 0.693 
MHC-II (+ve) peritumour 9.07 0.07 18.84 541 0.03* 
Sex Male * MHC-II (+ve) 
peritumour 





Intercept -275.06 -576.86 -1.59 972 0.01* 
Sex Male 16.16 -445.32 454.79 1977 0.91 
MHC-II (+ve) intra-
tumour 
5.74 -4.27 17.55 1171 0.23 
Sex Male * MHC-II (+ve) 
intra-tumour 




Intercept 60.27 -270.91 396.70 126 0.62 
Sex Male -129.17 -707.87 514.83 355 0.60 
CD3 (+ve) peri-tumour -15.27 -38.42 6.17 108 0.11 
Sex Male * CD3 (+ve) 
peri-tumour 




Intercept -60.90 -432.54 312.71 1539 0.73 
Sex Male -233.78 -838.05 255.84 1675 0.34 
CD3 (+ve) intra-tumour -5.35 -18.80 8.00 1579 0.38 
Sex Male : CD3 (+ve) 
intra-tumour 
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Figure 5-2 Probability for tumours to be classified as “Progressing” and “Non-Progressing” 
by the histopathological findings in tumour sections: A) MHC-II (+ve) cells in peritumour 
tissue; B) MHC-II (+ve) cells inintratumour tissue; C) CD3(+ve) cells in peritumour tissue; and 
D) CD3(+ve) cells in intratumour tissue. Points in the graphs show the classification of the
observed tumours: “Progressing” (0) and “Non-Progressing” (1) in male (light blue triangles)
and female (orange circles) hosts.
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5.4. Discussion 
Overall our findings suggest that wild Tasmanian devils show signs of humoral 
immune responses against DFTD which may differ between males and females, while in 
infected individuals antigen presenting cells around tumour tissues may influence tumour 
growth rates. We found that the presence of specific antibodies (IgG) against DFTD showed 
a positive relationship with infection status in males while not in females. Once individuals 
were infected, the rate of tumour progression showed an inverse relationship with the number 
of antigen-presenting cells in peritumour tissues; their numbers associated with slower than 
expected growth rates in tumours. That DFTD progression is being influenced by the devil 
immune response suggests that, not only can a proportion of individual devils in the 
population recognise tumour cells and mount an immune response, but that devils may 
present some level of resistance to the cancer. These results, linking immune response to 
functional influence on tumour progression, expand our knowledge of the devil-DFTD 
system and have implications for the epidemiology and evolution of this cancer-host system. 
DFTD is transmitted from infected hosts to naïve hosts by bites during social 
interactions. Social contacts involving biting increase with body size as individuals reach 
sexual maturity in both sexes (Hamede et al., 2013). Our results reflect this pattern, with 
probability of infection increasing with head width. Sex differences in allometric growth 
curves explain why the exponential increase in infection probability occurs at a smaller body 
size in females and may also influence the body size and age at which males, but not females, 
are exposed to DFTD. Growth asymptotes at a smaller size and younger age in female 
(generally age 2 years) than it does in male devils (at least 3 years). Nearly all females will 
breed at sexual maturity in their second year, irrespective of body size, or in their first year in 
diseased populations if nutrition and growth rate are sufficient (Lachish et al., 2009). 
Females, then, will be exposed to DFTD once they reach sexual maturity as they will come 
into oestrus, mate, and be exposed to injurious biting. Reproductive skew and male 
competition will dictate that larger males have greater access to females (Jones, unpublished 
data). Thus, larger males and, older males in disease-free populations, are more likely to gain 
mating, and thus become exposed to DFTD.  
Production of DFTD-specific antibodies (IgG) is a consequence of activation of an 
immune response against DFTD (Pye et al., 2018, 2016; Tovar et al., 2017), and our results 
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suggest that this also differs between males and females. The statistical support for sex 
differences in the relationship between IgG and infection status suggests differences between 
male and female devils in immune recognition of tumours. In the case of males, there is a 
positive significant relationship between antibodies and the probability of presenting tumours 
which reaches 100%, at high values of MFI. In contrast, this relationship in females, although 
follows a positive trend, was not significant. Assuming that an increase in IgG levels relates 
to exposure to the tumour antigens (Kreiss et al., 2015; Pye et al., 2018). Our findings 
support that immune recognition of tumour cells differ between males and females. Potential 
explanations of this pattern may be associated to the level of antigenicity of tumour cells or 
timing of activation of the immune response in relation to the moment of clinical detection of 
tumours.  
The significant relationship between the number of antigen-presenting cells in the 
peritumour tissue and tumour progression supports an interaction between tumour growth and 
the immune response of devils. Infection represent an important pressure on hosts to develop 
strategies to optimize their fitness (Ruiz-aravena et al., 2018), therefore it is expected that 
resistance in the form of immune response against DFTD may emerge as one strategy that 
devils may mount to reduce the detrimental effects of DFTD. However, the emergence of 
resistance against the cancer may select for counter measures from the tumours to evade the 
immune response mounted by their host. In the first case, our findings may be interpreted as 
that an increased number of APCs in the peritumour tissue have a suppressive effect on 
tumour growth. However, an alternative hypothesis might be formulated from our findings 
supporting that fast growing tumour may reduce the recruitment of APCs in the surrounding 
tissues, and thus tumours could counter-act the resistance response from the host by 
modulating the response itself.  
Evidence of potential resistance was recently described by Pye et al (2016), however 
the authors did not present direct evidence of the functional impact of the immune responses 
on cancer progression. Devils may mount an immune response by first recognising antigenic 
molecules in DFTD cells (Kreiss et al., 2015; Tovar et al., 2018) which may trigger antibody 
production, and eventually by stimulating a cell-mediated immune response against the 
growing tumour resulting in limitation of tumour growth and thus fitness (Kreiss et al., 2015; 
Pye et al., 2016; Tovar et al., 2017). This chain of events in the activation of an immune 
response against DFTD infection is supported by experimental infections and immunotherapy 
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(Tovar et al., 2017). Resistance is not widespread within the devil populations studied at 
present, however it is expected to be under selection pressure, and therefore increase its 
frequency in the future. In this context, individual heterogeneities in the capacity of devils to 
respond to the infection by DFTD may allow for natural selection to operate in favour of 
resistant phenotypes which may increase the spread of resistant genotypes in the populations 
over time (Margres et al., 2018).  
  One of the most remarkable features of Devil Facial Tumour Disease is its capacity 
to escape the immune system of multiple hosts, and therefore prevent immune rejection 
(Siddle et al., 2013; Siddle and Kaufman, 2013). This trait has been crucial for the evolution 
of transmissibility in this cancer (Siddle et al., 2007), however immune escape is apparently 
not perfect (Pye et al., 2016). Immune responses against DFTD have been induced in devils 
by immunisation of susceptible individuals with tumour antigens, demonstrating that the 
devil immune system is competent (Woods et al., 2007) and that immune responses are 
usually prevented by the down-regulation of MHC-I molecules in tumour cells (Pye et al., 
2018; Tovar et al., 2017). The ability of tumours to “hide” their antigens is a hallmark of 
cancer and has been proposed to be adaptive, and therefore a loss or decrease in its capacity 
will negatively impact tumour fitness (Cavallo et al., 2011; Hanahan and Weinberg, 2011). 
This condition raises questions and provides room for further inferences about the benefits of 
MHC-I expression for cancer, which may differ according to whether tumours act as a 
community of cells in coordination or as a group of cells in isolation (Romero et al., 2018). In 
the case of DFTD, if the tumour tissues act as coordinated cells, the expression of MHC-I, 
which will trigger an immune response from the host, may be adaptive or maladaptive in 
different scenarios. MHC-I expression will be adaptive when stimulation of immune response 
increases host tolerance by reducing tumour growth rates and host mortality while increases 
infectious time. As a result, the probability of transmission to a new host will be higher 
fixating the alleles behind (Roy and Kirchner, 2000). In contrast, the expression of MHC-I on 
tumour cells and the consequent induction of immune response may be maladaptive when it 
results in tumour remission and therefore in a reduction of tumour fitness. This scenario will 
change if DFTD tissues act as a heterogeneous cell population in which each cell optimizes 
its own fitness within the tumour. In this case, the expression of MHC-I can derive from 
individual cells or lineages within tumours, for which the benefit may come from a reduction 
of competition by inducing an immune response from the host (Gatenby et al., 2009). Thus, 
the immune response would act similarly to therapies in cancer in which treatment results in 
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selection that favours cell lines resistant to the treatment (Dagogo-Jack and Shaw, 2017; 
Shlush et al., 2017). Considering the clonal nature of DFTD (Murchison et al., 2010; Pearse 
and Swift, 2006), we could expect tumours to act as coordinated entities since cells are highly 
similar in their genetic material, however the emergence of different tumour lineages may be 
explained by the heterogeneous interests among cells within tumours (Murchison et al., 2012; 
Pearse et al., 2012; Ujvari et al., 2013).  
5.4.1.  Future directions 
DFTD represents a strong selective force acting on populations of Tasmanian devils. 
Disease progression impacts the energetic budget of individual devils (Chapter 2), and in 
males, the energetic demand reaches levels similar to the mating season which is the most 
energetically costly time of year for males (Ruiz-Aravena et al., 2018). Accordingly, traits 
that enhance tolerance and resistance to DFTD are predicted to be selected for in infected 
populations (Margres et al., 2018; Ruiz-Aravena et al., 2018; Storfer et al., 2018). This 
functional link between immune responses and disease progression supports the idea that 
resistance to cancer happens in natural conditions and is likely to positively impact the fitness 
of hosts. Further research exploring immune responses in devil populations in relation to 
disease arrival, and the underlying mechanisms is paramount to understand the potential for 
evolution of resistance to cancer in devil populations.  
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 GENERAL DISCUSSION 
6.1. Research summary 
This thesis integrates the fields of veterinary sciences, ecological physiology and eco-
immunology to understand the physiological dimension of an evolutionarily young host-
pathogen interaction between the Tasmanian devil and its transmissible cancer. By using a 
field-based methodology and a combination of observational and experimental approaches, I 
explored the applicability of the well-developed host-pathogen theory (HPT) to the recently 
emerged DFTD. The HPT predicts the occurrence of phenotypic traits in both host and 
pathogen which may act to favour tolerance and resistance to infection in the hosts. In this 
thesis, I assessed the overall physiological impact of DFTD progression in wild devils, 
identifying patterns of tolerance and resistance. As DFTD progresses, the metabolic demand 
in infected devils increases and their overall health decreases. The pattern of decline in health 
is different for male and female hosts, with females tolerating the infection better than males. 
Differences between the sexes were also found in the immune response against infection by 
DFTD and general immune condition of devils. This thesis provides the first knowledge of 
patterns of tolerance and resistance to DFTD in devils and of their relationship to cancer 
progression. The results of the study have important implications for current conservation 
actions for the species, as well as to inform theory and to predict potential ecological and 
evolutionary trajectories that the devil-cancer system may follow. In this discussion, I will 
develop some of the ideas, and potential predictions that can be drawn from the results of 
four years of research. 
6.2. On the metabolic extended phenotype of the devil-DFTD system. 
The extended phenotype, a concept coined by the evolutionary biologist Richard 
Dawkins (Dawkins, 1982), takes relevance in the case of host-pathogen interactions. The 
conceptual idea proposed by Dawkins refers to how phenotypic traits are not just the result of 
an organism’s genotype and its interaction with the surrounding environment, but it is also 
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result of an organism’s genotype interacting with other genotypes, for example a pathogen 
genotype. From this idea, phenotypic traits in an infected host will depend on the host 
genotype, but also on the genetic background of the pathogen (Casadevall and Pirofski, 2001; 
Qiu et al., 2014; Råberg, 2014). Therefore, host responses to infections may result from 
genetic differences among hosts, and/or from differing pathogen strains (Gagneux, 2012). In 
applying this concept to the devil-DFTD system, it is expected that the ecological 
performance of an infected devil will be influenced both by its own genetic background and 
that of the growing tumour. Having in mind that HPT predicts that hosts and pathogens, at the 
individual level, constantly compete to optimize their fitness, the resulting phenotype from 
their interactions will define their potential for selection on traits that may optimize both host 
and pathogen fitness (Boots and Bowers, 1999; Cronin et al., 2010; Griette et al., 2015; 
Hayward et al., 2014; King et al., 2014; Svensson and Råberg, 2010). These individual-based 
interactions would therefore favour host and pathogen genotypes in which their resulting 
extended phenotype may drive the system toward coexistence.  
The enhanced metabolic demand found in devils infected with DFTD is expected to 
shape both devil and tumour life history. Life-history theory proposes that multiple organic 
functions relate in a trade-off and the optimal combination of them will depend on the 
ecological circumstances in which organisms occur (Stearns, 1976). While acquisition of 
nutrients by organisms is linear, their allocation to multiple organic functions (fitness 
components) occur in parallel, and therefore the use of energy in one function represents a 
cost of opportunity to another one (Lailvaux and Husak, 2014; van Noordwijk and de Jong, 
1986). As a result, natural selection is expected to act in favour of strategies that optimize 
fitness according to the limiting resources (Bêty et al., 2003; Jones et al., 2008; Knutie et al., 
2017; Ricklefs and Wikelski, 2002; Thornton, 2008). How energy budgets are assigned to 
different functions changes along the lifespan of organisms. For instance, during early life, 
reproduction is suppressed since growth is the main energetic demand (Figure 6-1A) 
(Folkvord et al., 2014; Grabowska et al., 2011). As a result, reproduction and positive fitness 
occur only when maintenance costs associated with somatic growth have ceased.  
The increased metabolic rate in devils as tumour burden increases represents a 
constraint for both devil and tumours at the same time, and therefore is expected to select for 
both devil and tumour genotypes that optimize their joint energy use and fitness. The 
consequences of the energy constraints on hosts and tumours may select for varying 
89 
 
strategies, for instance, reduction in host maintenance costs which might allow them to cope 
better with the demand from the growing tumour (Figure 6-1C and 6-1F). This may be the 
case with infected females, which may adjust litter size to increase their level of tolerance, in 
relation to the capacity of males to tolerate the infection. As metabolic costs in organisms are 
one of the main forces driving the optimization of adult body size and lifespan (Speakman, 
2005), a potential consequence of DFTD in long-term infected areas may be the reduction of 
devil body size resulting from selection on early sexual maturity and breeding. Increased food 
resources consequent to severe population decline leads to increased growth rates of juveniles 
and up to 50% of females that are able to reach a threshold body mass in May of their first 
year of independent life, just three months after weaning, to be able to come into oestrus and 
breed (Lachish et al., 2007). Plasticity in growth rates has allowed devils to increase the rates 
of precocial breeding in infected devil populations in comparison to healthy ones (Jones et 
al., 2008; Lachish et al., 2009). This strategy of early reproduction represents an energetic 
trade-off with early death by DFTD infection (Jones et al., 2008; Lachish et al., 2009) but 
would come at a cost on somatic growth (Johnson et al., 2012; Wells et al., 2017). This 
pattern is expected to select for fast growing/early reproducer individuals at a cost on adult 
body size (Hou et al., 2008) or immunity consistent with the “live fast, die young” paradigm 
(Johnson et al., 2012; Promislow and Harvey, 1990). From the tumour perspective, constraint 
in energy supply would directly affect its growth rate. As a result, tumour variants capable of 
growing at rates in synchrony with energy acquisition by the host may be favoured by 













Figure 6-1 Scenarios of relationship between energy budget required/available for an organism 
and its age. Green lines parallel to the x-axis represent the minimum energy required to start 
reproduction, the upper red line shows the maximum energy budget available for an organism, 
and the blue dashed line parallel to the y-axis represents the age of first reproduction. The 
intersection of these lines represents different fitness scenarios (1 – 5) in the life of an 
organism.  Area 1 represents scenarios of fitness 0, fitness may be positive in some contexts in 
areas 2 and 4, while area 3 represents the positive fitness in an organism’s life. Area 1 = 
organism is too young, and energy available too low for reproduction; Area 2 = Energy 
available enough for reproduction, but organism is too young; Area 3 = energy available, and 
age enough for reproduction; Area 4 = organism at reproductive age, but low available energy; 
and Area 5 = Energy available, but reproduction is suppressed by senescence. A) Relationship 
of energy budget and age of an organism in “neutral conditions”, with no selective pressure on 
energy allocation. B and C show maximization of fitness by plasticity in age of first 
reproduction, and energy required. Selection on energy allocation may operate on either or 
both strategies at the same time. Graphs D – F present scenarios of energy demand considering 
cancer progression, (green arrow). D) Energy demand increases as tumour burden increases at 
levels that do not allow for reproduction, driving host to death. E) Selection on plasticity of 
age at first reproduction allows host to present positive fitness. F) Selection on (s)lower energy 
demand from cancer progression allows host positive fitness. Selection may act on either or 




6.3. Differential force and direction of selection is expected on devil and 
tumour traits. 
The host-pathogen theory predicts contradictory trajectories in the evolution of the 
systems according to the traits in play. For instance, while tolerance in hosts may drive host 
and pathogen genotypes toward a stable evolutionary dynamic, the emergence of host 
resistance could trigger an “arms race” or “red queen” dynamic, which is highly instable 
(Best et al., 2014; Roy and Kirchner, 2000). If there is spatial heterogeneity or sex 
differences in the emergence of traits, such as the ones described in this thesis for tolerance 
and resistance, are added to the system, the result is a mosaic of costs/benefit balance across 
traits that will vary across population (Gomulkiewicz et al., 2000). How resistance and 
tolerance are theoretically expected to interact and how they might do so in the devil-DFTD 
system is explored in Figure 6-2.  
The four traits that define a host pathogen system can be allocated along two axes 
connecting the host and pathogen genotypes (Figure 6-2). Tolerance is considered as a host 
trait, which relates in an inverse shape with virulence that is its pathogen counterpart (Little et 
al., 2010). In the case of host resistance to infection, an increase in it translates in a reduction 
in pathogen transmission. Relationships between the traits also occur within host and 
pathogen genotypes, commonly in a trade-off situation. In the case of hosts, an increase in 
resistance is expected to trade-off with tolerance since a completely resistant host would not 
become infected, and therefore it would not experience any ecological pressure to cope with 
the infection (Råberg et al., 2007). Consequently, no reaction norm between host health and 
pathogen burden can be built since pathogen burden remains at zero level in a complete 
resistant host. For pathogens, a similar trade-off might occur between virulence and 
transmission. Since transmission is influenced by how long a host may remain infectious and 
releasing pathogens to the environment, highly virulent pathogens that decrease host health 
too quickly result in a reduction of infectious time by hosts dying fast (Martin et al. in press). 
This results in a reduced transmission potential in comparison to a less virulent pathogen. 
From these last relationships we can build the last interactions between traits. Since virulence 
relates in an inverse shape with tolerance, the latter will relate positively with transmission by 
increasing the time in which hosts remain infectious (Roy and Kirchner, 2000; Martin, et al. 
in press). On the other hand, resistance will also relate in a positive way with virulence, since 
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when hosts become more resistant, a positive selective pressure for pathogens with virulence 
factors that increase their chances of transmission will be favoured (Gates et al., 2014; 
Mackinnon and Read, 2004). Although tolerance and resistance are traits predicted by the 
HPT to emerge in host populations as a selective pressure by infections, whether they occur 
or not in the devil-DFTD system was completely unknown until their description in this 
thesis. Both traits are present in the devil populations and therefore are expected to be 
adaptive for devils. It is interesting that both traits, resistance and tolerance, may present sex 
differences which are expected to drive selection for tumours and therefore the epidemiology 
of DFTD in different directions by female and male devils. Thus, females, being more 
tolerant to DFTD progression, are expected to favour stable evolutionary strategies in the 
system by favouring less virulent tumours. On the other hand, the sharp decline of health 
experienced by males, that can reach about 25% of their body condition, may act against 
tumours infecting them by reducing chances of transmission. However, this outcome may 
change if males increase social interactions when infected to increase their chances of mating 
in a terminal investment effort. This scenario of terminal investment in male devils may be 
supported by the findings of larger size of sexual glands in late-DFTD infected males in 
relation to healthy males (Keeley et al., 2012). Another potential consequence of the higher 
tolerance to infection in females is that they may act as super-spreaders (Martin et al., in 
press), or keystone hosts allowing the tumour lineages to persist in the devil population until 
the next mating season. This condition seems highly unlikely for males as their rapid decline 
in body condition compromises their survival after they become infected.    
Resistance against DFTD in devils may select for higher virulent tumours. Host 
resistance involves a cost on pathogen fitness (Råberg et al., 2009), which in the case of 
DFTD translates into a reduction in growth rates or even complete tumour regressions, as 
presented in chapter 5. This restriction of tumour fitness by devil immune response is 
expected, according to the HPT, to act as a selective pressure on tumour cells to develop 
strategies to avoid or modulate the immune response from its host (Mackinnon and Read, 
2004; Siddle et al., 2013). For instance, in the case of the oldest known transmissible cancer, 
the canine transmissible venereal tumour, the tumour tissue takes advantage of intimate 
manipulation of the host immune response to optimize its fitness by modulating its own 
growth rate. Normally undetectable by the dog immune system, CTVT presents an infinite 
replication capacity which may threaten the survival of its host as tumours grow, and 
therefore its own transmission. Thus, CTVT modulates its own growth and size by 
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stimulating an immune response from the dog host, thereby decreasing the risk of death for 
both tumour and host. This process is reversed by posterior down-regulation of antigenic 
molecules on the surface of tumour cells when the immune response threatens with clearing 
the cancer completely.     
6.4. Evolutionary and adaptive medicine for devil conservation 
Design and application of conservation strategies when outbreaks of an infectious 
disease are the dominant threat to a species is a challenging task. By default, pathogen 
eradication is the ideal scenario when it comes to disease management. Examples of 
successful interventions to control disease outbreaks in livestock, and human health are vast, 
however in the case of wildlife they are scarce. One of the main challenges for controlling 
wildlife diseases is the applicability of conventional health management strategies in an 
imperfect way, since access to whole populations is logistically and economically prohibitive. 
A second challenge, this time from the biological perspective, emerges from the condition 
that any intervention to increase the fitness of the host species (usually the goal of 
conservation strategies) may incur costs for the pathogen fitness. This might result in an 
important biological constraint for long-term conservation, where the main goal is to assist 
species populations to become self-sustainable to persist in the wild.  Genetic diversity is 
crucial for the adaptive capacity of populations and species. The classical view of the 
influence of genetic variability in the viability of populations have supported that the higher 
the variability the better. The low genetic variability that Tasmanian devils present in the 
MHC-I alleles has been the most supported hypothesis for the emergence and spread of 
DFTD (Pye et al., 2015; Siddle et al., 2013, 2007). Based also in the low genetic variability 
of devils, is the contention that the species was thought to present very limited capacity to 
respond to the selective pressure imposed by the disease (Morris et al., 2013), however devil 
populations seem to be rapidly evolving, and potentially adapting to DFTD (Epstein et al., 
2016; Hubert et al., 2018; Margres et al., 2018). The rapidity of the evolutionary response in 
devils means that adaptation is operating on standing genetic variation, that is, the genetic 
variation already present in the devil’s genome at the time of the DFTD outbreak (Epstein et 
al., 2016). This means that, despite loss of genetic diversity during the Last Glacial 
Maximum (LGM) and the Holocene (Brüniche–Olsen et al., 2018, 2014), devils have the 
capacity in their genomic diversity to adapt to this recent disease challenge. This body of 
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evidence inspires a new view of “The right genetic diversity is better than more diversity” in 
the case of the devil-DFTD system. 
Theoretical and empirical studies support the notion that hosts, and pathogens interact 
in a very intricate way. Changes in phenotypic traits in the hosts act as ecological and 
evolutionary pressure for the expression of traits in pathogens, and vice versa. In this 
scenario, increases in host resistance may likely result in an arms race between devils and 
tumours due to the decrease in transmission which might favour the emergence of more 
virulent DFTD variants. Although some theoretical studies support that both resistance and 
tolerance to infection can occur simultaneously in host populations (Restif and Koella, 2004), 
Figure 6- 4 Schematic representation of the interplay between the four traits identifiable in a 
host-pathogen interaction: Host resistance and tolerance to infection, and pathogen virulence 
and transmission. Traits allocated at the extreme of the same axis present inverse relationship 
(e.g. host resistance, translate in lower pathogen transmission). The large triangles represent 
whether traits depend on genotypes of host (beige) or pathogen (light blue). Red lines show 
the expected negative correlation between virulence and transmission in the pathogen 
genotype, and tolerance and resistance in the host genotype. The purple dashed lines show 
the positive correlation between host and pathogen traits. The extended phenotype of the 
interaction between host and pathogen genotypes can be visualized by the yellow bars along 
the axes. In the depicted example, the host – pathogen interaction presents high host 
resistance, low tolerance, low transmission rate, and high pathogen virulence. 
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the limited knowledge of these traits in the devil-DFTD system restrains the capacity to 
foresee the impact of actions to booster resistance or tolerance in devil populations. The 
current efforts to develop a vaccine against DFTD and the ongoing trials releasing immunised 
captive and semi-captive bred individuals into the wild are likely to change the transmission 
dynamic of DFTD by increasing resistance in hosts. How these management actions will 
affect the ongoing evolution process between devil and tumours remains to be elucidated, 
however a potential increase in tumour virulence is a likely outcome.  
Regardless of the strong predictions of devil extinction due to DFTD outbreaks that 
early epidemiological models supported, Tasmanian devils have persisted in the long term in 
infected areas. Demographic compensation, driven by earlier sexual maturity and 
consequential reproduction of juveniles, is one of the main mechanisms by which devils 
might be persisting (Jones et al., 2008; Lachish et al., 2009). Another potential explanation is 
the metapopulation structure (Siska et al., 2018) and the relationship between sexual maturity 
and transmission. Thus, disease spread may fragmentate metapopulations and by 
geographical configuration isolate subpopulations in which adults are eliminated by DFTD-
induced mortality, recolonization by healthy juveniles from near areas may support and 
rebuild devil numbers. Although these mechanisms may take place and could be included in 
epidemiological models of the disease, the models would still lack the potential adaptive 
component described in this thesis. Host heterogeneities in tolerance and resistance are very 
likely to influence host competence, which translates into changes in transmission dynamics 
(Martin et al., 2016; Vazquez-Prokopec et al., 2016). Therefore, given that transmission is a 
key component of infection, considering how tolerance and resistance influence the epidemic 
behaviour of DFTD by influencing the physiological and behavioural dimensions of host 
competence is paramount to forecasting the future of the Tasmanian devil in the wild.  
An increasing body of evidence, from both genomic and phenotypic studies, suggests 
that evolution can happen over short timescales, contrary to the classical view of natural 
selection acting on scales of millions of years  (Kinnison and Hairston, 2007; Levis and 
Pfennig, 2016; Smith et al., 2014). The devil—DFTD system demonstrates that these changes 
can occur as fast as in four to six generations (Epstein et al., 2016; Margres et al., 2018), 
which is much more rapid than, for example, the classic case of the European rabbit—
Myxoma virus system in which rabbits evolved resistance over 20 generations (Di 
Giallonardo and Holmes, 2015). With evolution occurring in the DFTD-devil system, and the 
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evidence supporting that both tumour and devils are changing (Storfer et al., 2018), the 
preservation of adaptive capacity of the system is a crucial new view and goal to be factored 
into strategies to preserve the species. This new framework based on the concept of “adaptive 
conservation medicine” provides a potential next-generation thinking for management of 
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